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ABSTRACT 
 
Background: Although the adoption of self-management behaviors is crucial for maintaining 
good health after a type 2 diabetes diagnosis, many individuals with T2DM fail to meet target 
blood glucose levels. Adherence to gluco-regulating behaviors like regular exercise and balanced 
diet can be challenging, especially for individuals of lower socioeconomic status (SES). 
Providing cost effective interventions that improve adherence to self-management behaviours is 
important for improving quality of life for patients and the sustainability of health care systems. 
Objective: To design and test a health coaching protocol administered by trained health coaches 
in a lower SES community aimed at improving the health profile of patients with poorly 
controlled T2DM, with and without smartphone connectivity. 
Methods: Dissertation methodology is described in two studies. The first study describes the 
pilot trial run at the Black Creek Community Health Centre (BCCHC) between February 2010 
and March 2011which recruited a total of n=21 participants intervened with by n=1 health coach. 
The second study describes the randomized controlled trial conducted primarily at BCCHC from 
March 2012 to March 2014 and intervened with n=131 participants with n=6 health coaches. The 
primary outcome is change in glycated hemoglobin (HbA1c) from baseline to 6-month follow-up 
for each study. Secondary outcomes include changes in weight, waist circumference, and BMI, 
as well as within group changes of HbA1c. Psychometric measures collected pre/post for the 
RCT include the Satisfaction with Life Scale, Positive and Negative Affect Schedule, Hospital 
Anxiety and Depression Scale, and the 12-item Short Form Health Survey (SF-12v2). 
Hypothesis: Patients who receive health coaching with electronic support will exhibit greater 
reductions in HbA1c than the health coach only group. There will also be greater improvements 
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in anthropometric and psychometric outcomes favouring the group who receives electronic 
support. 
Results: In the pilot study, a total of 21 individuals consented to participate, of whom 19 
(90.4%) completed the 6 month trial; 12 had baseline glycated hemoglobin (HbA1c) levels 
>7.0% and these participants demonstrated a mean reduction of 0.43 (0.63) (p<.05) with minimal 
changes in medication. In the RCT, a total of 131 patients were randomized, with n=67 and n=64 
in the intervention and control groups, respectively. Primary outcome data were available for 
n=97 participants (74%). While both groups reduced their HbA1c, there were no significant 
between-group differences in change of HbA1c at 6 months using intention to treat (LOCF) 
(p=.481) or per protocol (p=.825) principles. However, the intervention group demonstrated an 
accelerated reduction in HbA1c, leading to a significant between groups difference at 3 months 
(p=.032). This difference was reduced at the 6 month follow up as the control group continued to 
improve, achieving an HbA1c reduction of 0.81% (8.9 mmol/mol) (p=.001) compared with a 
reduction of 0.84% (9.2 mmol/mol)(p=.001) in the intervention group. Intervention group 
participants also had significant decreases in weight (p=.006) and waist circumference (p=.011) 
while controls did not. Both groups reported improvements in mood, satisfaction with life and 
quality of life. 
Discussion: Health coaching with and without access to mobile technology appeared to improve 
gluco-regulation and mental health in a lower SES, T2DM population. The accelerated 
improvement in the smartphone group suggests the connectivity provided may more quickly 
improve adoption and adherence to health behaviors within a clinical diabetes management 
program. Overall, health coaching in primary care appears to deliver significant benefits for 
patients from lower SES with poorly controlled type 2 diabetes. 
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CHAPTER 1: INTRODUCTION 
1.1 OVERVIEW OF DISSERTATION 
 
The sustainability of Canada’s health system depends on the management and prevention 
of chronic diseases including Coronary Artery Disease (CAD) and Type 2 Diabetes Mellitus 
(T2DM). Diabetes is particularly important because current and future estimated prevalence rates 
coupled with the predictive relationships between T2DM with CAD [1], cancer [2] and other 
severe illnesses suggest significant strain on healthcare system resources [3], while continued 
improper management of the condition will lead to accelerating costs that could overwhelm the 
system [4]. 
This dissertation describes my recent efforts to develop and study a novel, evidence-based 
health coaching intervention coupled with a mobile health software application for improving the 
overall health of individuals with T2DM. In the first section, I describe the prevalence, 
pathophysiology, comorbidities, and complications of T2DM to illustrate the severity of the 
problem and the need and opportunity for behavioural interventions such as ours. The next 
chapter encapsulates the pilot trial run at the Black Creek Community Health Centre (BCCHC) 
between February 2010 and March 2011 (Chapter 2). Pilot study results with 21 participants and 
1 health coach lead to grant funding from the Public Health Agency of Canada (PHAC) 
($175,000) and the Federal Development Agency of Southern Ontario (FedDev) ($100,000), 
which provided funding for the randomized controlled trial (RCT). The RCT (Chapter 3) was 
conducted primarily out of BCCHC from March 2012 to March 2014 and intervened with 131 
participants with 6 health coaches. The dissertation concludes with a summary of findings and 
recommendations for further research. 
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1.2 TYPE 2 DIABETES MELLITUS 
1.2.1 Prevalence 
The concern surrounding T2DM is due mainly to escalating rates and the risk of 
dangerous and costly complications, as well as worsening quality of life when the condition is 
poorly managed. While best practices for management of this disease are well known, medical 
interventions are only effective when supported by permanent lifestyle changes in diet, physical 
activity, and medication adherence. In Ontario, latest estimates (2012) indicate approximately 
1,100,696 Ontarians (10.2%) of the population have diabetes, compared with 8.4% Ontarians in 
2008, representing a 28.3% increase in prevalence, or an additional 242,886 diagnosed 
individuals [5] while Canada as a whole has 2.8 million diabetics [6]. In the United States, it was 
estimated 26 million individuals had T2DM in 2010, while 79 million had pre-diabetes, leading 
researchers to estimate that without intervention, rates will reach 1 in 3 persons by 2050 [7]. 
Although diabetes has been a condition typically afflicting developed nations, evidence now 
suggests the majority of individuals with diabetes (80%) live in low- and middle-income 
countries [8]. To put this into perspective, estimates in 2013 suggested that diagnosed diabetics 
in the US numbered between 24.4-29.1 million [8,9], dwarfed by China with 98.4 million and 
India with 65.1 million [8] indicating the international impact of diabetes as well as its impact in 
North America.  
1.2.2 Economic Impact 
In 2014, the Ontario budget for the Ministry of Health and Long Term Care (MHLTC) 
was $48.7 billion, equal to approximately 40% of the province’s gross budget [10]. Accounting 
for both direct medical costs (emergency room visits, doctor’s appointments) and indirect costs 
(loss of income from missed work), diabetes cost the public system $4.9 billion in 2009, a cost 
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predicted to increase to $7.0 billion by 2020 [3]. Coupled with demographic shifts towards an 
older population, the increasing costs of diabetes treatment relative to overall health expenditures 
is significant in an already resource-stretched health care system. As expenses increase, without 
simultaneous increases in funding, there must be a redirection of funds from the management, 
treatment, and service provisions for other conditions. From a cost perspective, conditions like 
T2DM where changes in individual behaviour directly lead to improved patient outcomes can 
provide the greatest return on investment (ROI) from behavioural intervention. Unlike 
medication-based interventions, individuals who successfully modify behaviour can conceivably 
maintain long-term adherence, deriving multiple years or lifelong benefits from a relatively brief 
intervention.  The potential cost savings achievable was demonstrated by Nundy et al. [11] who 
assessed a smartphone-based, automated text messaging and counselling intervention with Type 
2 Diabetes patients. In a quasi-experimental, two-group, pre-post design, intervention 
participants appeared to be 8.8% less costly during the 6-month intervention than during the 6 
months preceding intervention engagement as measured by hospitalizations and visits to 
physician offices. These subjects also reduced their HbA1c by an average 0.7%, leading to other 
potential longitudinal savings not included in the analysis. Because all subjects were participants 
in the University of Chicago employee health plan, relevant health care cost data were accessible 
although all individuals were insured (in the US) and employed, and from mid-level socio-
economic strata (SES) or above. This intervention was based on a standardized curriculum 
delivered to participants mostly through an online portal controlled by registered nurses who 
only spoke in person to participants when an exceptional situation was indicated by the 
participant. The quasi-experimental design also left this trial vulnerable to selection bias as all 
their intervention participants chose to receive the intervention and their control group either 
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refused or was unable to be contacted. As well, a factor leading to the health care costs 
reductions of the intervention group could have been because they had phone and text access to a 
registered nurse who was able to advise them on concerns which would have lead them to visit 
their family physician or the emergency room without that medical reassurance.  
1.2.3 Social Determination 
The healthy self-management of T2DM require behavioural changes, yet research on the 
promotion of such changes remains modest when compared with other chronic diseases, with 
few studies addressing individuals from lower socio-economic-strata (SES). Research involving 
individuals with T2DM at lower SES are particularly important because findings related to the 
social determinants of health suggest SES and educational status (a standard SES proxy) predict 
costly T2DM complications [12]. In Canada, data from the Canadian Health Community Survey 
(2005) suggest individuals from the lowest income group are 4.14 times more likely than the 
highest group to have T2DM [13], while less walkable neighbourhoods [14], where lower 
income individuals frequently reside [15], also increase risk for T2DM development and hamper 
management following diagnosis [16]. 
  As Canada's population grows and new Canadians comprise an increasing proportion of 
the population, their health and health care utilization become increasingly important for long-
term system sustainability. In the Study of Health Assessment and Risks in Ethnic Groups, it was 
found that significantly higher rates of type 2 diabetes were found amongst Indo-Asians 
compared with other Canadians [17]. Despite this predictable impact and the surges of interest in 
obesity and disease incidence, relatively little attention has been paid to urban, low SES, 
immigrant/minority groups. As an example from the United States, the US Federal agency 
charged with supporting research to improve health care quality and broaden access to essential 
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services (the Agency for Health Research Quality), conducted a MEDLINE review of research 
on diabetes in minorities in the US published from 1976-1994. In 290 articles, it was found that 
all US minorities, except Alaskan natives, had a prevalence of T2DM 2 to 6 times greater than 
that of the Caucasian population. Improving the lipid profile of African Americans with diabetes 
could help lower the prevalence of diabetes-related cardiovascular disease, and implementing 
interventions sensitive to cultural and population-specific characteristics could help reduce the 
prevalence/severity of diabetes and its resulting complications [18]. 
  The lived experience of individuals from lower SES populations reflects the struggle and 
frustration experienced when managing T2DM with limited resources. Researchers from York 
University using semi-structured interviews and qualitative analysis spoke with 60 individuals 
living with diabetes in low SES communities in the City of Toronto [19]. Several themes that 
recurred across interviews cemented the importance of patient-centred care, especially as poverty 
is considered a risk factor for developing T2DM as patients have difficulties accessing resources 
to manage their condition. 
  Another important consideration in the development of T2DM is the exposure to 
psychological trauma and the presence of Post Traumatic Stress Disorder (PTSD). Some 
literature has demonstrated a connection between early childhood trauma as a predictor of 
elevated blood lipid profile in men from lower-SES community [20] and a dose response 
relationship with moderate to severe physical and sexual abuse in childhood or adolescence and 
the onset of T2DM in adult women [21]. Miller et al. [22] reported that in a lower SES, 
multiethnic community in New York that 24% of T2DM patients presented clinical or 
subclinical PTSD. The majority of participants (79%) reported at least one traumatic event and 
24% reported early childhood abuse. As well, patients with PTSD had significantly greater 
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HbA1c levels compared to those without (7.3% vs. 6.9%, p=0.03). As these connections 
between victimization in early age [23] and as an adult [24] and T2DM has been well replicated, 
interventions aimed at seeking to enhance self-management of T2DM should incorporate 
trauma-informed service delivery into such protocols [25]. 
1.2.4 Pathophysiology of DM 
Glucose is necessary for healthy physical and mental functioning. The ingestion of 
glucose signals release of the hormone insulin from pancreatic beta-cells and insulin binds to 
glut-4 receptors on muscle cells, opening the protein transporter bringing glucose into the cell. 
Glucose is metabolized by the mitochondria to produce Adenosine Triphosphate (ATP), which 
ultimately powers cellular function. Diabetes is characterized by poor regulation of this system 
and a reduced ability to metabolize sugars, typically referred to as glucose intolerance. Glucose 
intolerance often progresses as a function of two distinct physiological phenomenon: 1) insulin-
producing pancreatic beta-cells decrease in number leading to less release of insulin into the 
body and available in the extracellular space; and 2) with fewer glut-4 receptors on muscle cells 
the efficiency of transporting glucose into the cells is also reduced, leading to a reduction in 
overall system efficiency [26]. While the exact aetiology of Type 1 Diabetes is unknown, it is 
believed to be predominantly an autoimmune disorder involving a swift and total destruction of 
pancreatic beta cells that necessitates supplementation (injection) of exogenous insulin as the 
main component of glucose regulation [27]. Type 2 Diabetes, in contrast, is a slow, progressive 
reduction of pancreatic beta cells exacerbated by decreasing insulin sensitivity (reductions in 
glut-4 receptor capacities). This gradual increase in glucose intolerance has a genetic component 
whereby individuals from certain ethno-cultural groups appear more prone to develop the 
condition [28]. Despite genetic influences, the most significant factor in the development of 
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glucose intolerance is behavioural – stemming from actions that produce chronically high serum 
glucose levels [27] suggests monitoring as an important step in glucose control. 
 When blood glucose levels are elevated, the pancreas responds by secreting insulin, 
prompting glucose uptake by various cells (skeletal muscle, liver, and adipose tissues) and a 
consequent drop in serum glucose. When serum glucose levels are chronically elevated, the 
pancreas begins down-regulating the number of beta cells, contributing to obesity [26]. When 
diet remains constantly high in sugar, without sufficient insulin (delivery or uptake) to facilitate 
the glucose transport into cells, serum glucose remains chronically elevated, leading to toxic 
effects, tissue damage, and eventual development of dangerous complications associated with 
diabetes. 
1.2.5 Complications 
 Complications associated with poorly managed T2DM can be profoundly debilitating and 
include vision loss, neuropathy, cardiovascular disease, limb amputation and death [27]. They 
result from the non-enzymatic attachment of glucose to body tissues (glycation) caused by 
chronic hyperglycemia [29]. Diabetes complications can for the most part be avoided by 
maintaining serum glucose levels approximating normal levels (i.e., less than 7.0mmol/L) [30], 
and HbA1c <6.0% [31]. Glucoregulation is evaluated using three types of tests: fasting plasma 
glucose, the oral glucose tolerance test, and glycated hemoglobin (HbA1c). HbA1c is especially 
useful as a direct measure of the glycation of hemoglobin and provides an excellent clinical 
indicator of gluco-regulation over a three-month period since red blood cells are renewed every 
three months. Although an HbA1c of less than 6.0% can be difficult to achieve with diagnosed 
T2DM, it is possible through medication adherence, regular exercise and a carbohydrate 
restricted diet [32]. 
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 Individuals with T2DM in comparison with healthy individuals are at a 1.5-2.5 greater 
risk at developing dementia [33]. The micro- and macro-vascular damage caused by chronic 
hyperglycemia increases the risk of developing complications by 4-15% for every 1% increase of 
HbA1c, while reducing HbA1c by 1% leads to a 21% reduction in risk of death from diabetes 
[31]. 
1.2.6 Comorbidities 
  Behavioural and psychological factors are heavily implicated in T2DM management. In a 
meta-analysis, Anderson et al. (2001) found approximately 20% of people living with diabetes 
experience depression, about double the depression rate in the general population [34]. It is 
possible that depression plays a causal role in T2DM to some degree, particularly as depression 
commonly predates T2DM onset [35,36]. Prospective studies have shown that depression (in 
those with no prior diabetes history) increased the likelihood of developing T2DM two-fold [37], 
while a recent meta-analysis determined depressed individuals are at a 41% increased risk of 
developing T1DM, and a 32% increased risk of developing T2DM, although the underlying 
causal mechanism remains unclear [38].   
Depression, anxiety, phobias and other psychological problems may also intensify the 
disease [39]. By definition, T2DM implies insulin resistance (i.e., cells unable to use endogenous 
insulin), resulting from chronic energy imbalances (i.e., too much energy intake and/or too little 
expenditure of energy) at least partly remediable and preventable by behaviour changes related 
to exercise and diet. However, these key changes are not often undertaken with sufficient 
consistency and intensity. This may be partly explained by the tendency of individuals to avoid 
hypoglycemic states that lead to symptoms like confusion/disorientation, shaking/trembling, 
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anxiety and even loss of consciousness [40], as well as the well-established difficulty of 
changing habits and making permanent lifestyle changes when will power is challenged [41]. 
Even mild hypoglycemic episodes are often unpleasant and occur about 1-2 times per 
week on average per diagnosed diabetic [40].  Although not associated with enduring negative 
effects, they can be alarming, and contribute to significant and immediate cognitive impairments 
[42]. Excess fears of hypoglycemia motivate a protective maintenance of higher blood glucose 
concentrations [43] which is a barrier to optimal glycemic control [40]. Individuals who maintain 
excessively high glucose concentrations are likely to develop significant microvascular and 
macrovascular complications [44]. At the other extreme are individuals who fear serious medical 
complications and consequently try to maintain lower mean blood glucose levels to minimize 
long-term risks. If blood glucose levels are managed too aggressively, some individuals risk 
severe hypoglycemic episodes [45]. 
Because of endocrine dysfunction, individuals with prolonged chronic hyperglycemia and 
poorly managed T2DM are often required to self-administer exogenous insulin through intra-
muscular injections. Consequently, clinical and sub-clinical blood-injection phobias can motivate 
avoidance and inconsistent pharmacological self-management [39]. The prevalence of specific 
phobias is estimated at 20% across diabetes subtypes, although the prevalence of specific blood-
related phobias is unclear. Yet, results of cross-sectional studies have shown that fears of blood 
and injury (assessed by self-report instruments) are inversely associated with the frequency of 
blood glucose monitoring and glycemic control [46,47] and are associated with an increased 
likelihood of such individuals developing macrovascular complications [46]. 
 Finally, the excessive worry characteristic of Generalized Anxiety Disorder (GAD) also 
co-occurs in individuals with diabetes with notable frequency. The prevalence of GAD in T1DM 
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and T2DM patients was estimated at 14% [48], about 2.5 to 3 times greater than the 4-5% 
prevalence in the general population of the United States [49]. Although there appears a 
significantly higher GAD (co-morbid) prevalence in individuals with diabetes, its effect on 
diabetes self-management behaviours is not entirely clear. Further research investigating this 
subpopulation is warranted.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
1.3 HEALTH MANAGEMENT BEHAVIOURS 
1.3.1 Exercise 
  Regular exercise has been shown to be effective for both prevention [50,51] and 
successful T2DM management [52,53]. According to the Canadian Diabetes Association’s 
(CDA) Clinical Practice Guidelines [30], individuals with T2DM should accumulate at least 150 
minutes of moderate intensity aerobic exercise over a 1 week period, and engage in resistance 
training for at least 20 minutes, 3 days per week [30]. Chronic sedentariness is strongly 
associated with increasing insulin resistance and glucose disregulation [54]. From a behaviour-
change perspective, an individual who has been mostly sedentary over years or a lifetime prior to 
diagnosis will likely have great difficulty making the changes necessary to meet the CDA 
guidelines post-diagnosis [55] due to reasons such as low motivation, low self-efficacy, 
discomfort, and lack of an understanding of exercise initiation. 
 The effects of physical activity on glucose regulation have been demonstrated in studies 
illustrating acute, post-exercise decreases in serum glucose levels as well as chronic increases in 
insulin sensitivity and action [56]. A comprehensive RCT by Sigal et al. [52] involved an 
intervention with 251 T2DM patients, employing a structured 22-week group exercise protocol, 
with assessments of the individual and combined effects of aerobic and resistance training in 
glucose regulation while maintaining stable pharmaceutical and diet regimens. Researchers 
found a 0.51% decrease in HbA1c in the aerobic only group (3 exercise-days per week), and a 
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0.31% decrease in the resistance only group when compared with the control group. Combined 
aerobic and resistance training demonstrated an additional decrease in HbA1c of 0.46%, 95% CI 
[0.09,0.83%] when compared to the aerobic only group and an additional decrease of 0.59%, 
95% CI [0.23, 0.95%] when compared with the resistance only group [52]. The findings of 
beneficial effects of combined resistance and aerobic training for patients with T2DM have since 
been replicated [53] and continue to be explored. 
Regular physical activity is essential for sustained health, with the potential to 
significantly reduce morbidity, mortality, and improve quality of life. Despite the well-studied 
benefits of regular physical activity in T2DM patients, there are few resources within Ontario’s 
health care system dedicated to assisting T2DM patients meet the recommended exercise 
accumulation indicated by the CDA [57]. As well, despite overwhelming evidence 
demonstrating the protective effects of exercise, it is estimated that only 15% of Canadians meet 
national recommended guidelines of 150 minutes of aerobic exercise and 2-3 sessions of 
resistance training per week [58]. Typically exercise needs are addressed by nurses and dieticians 
on diabetes education teams, who are unable to provide exercise prescriptions, leading to a 
consensus amongst many health care providers, that qualified exercise specialists are needed on 
diabetes teams [57,59]. 
1.3.2 Diet 
 Due to the body’s decreased ability to metabolize sugar, carbohydrate restricted diets are 
recommended to improve glucoregulation in patients with T2DM [60]. Carbohydrate restriction 
must be carefully regulated when patients are taking medications that effectively decrease serum 
glucose, as the combination elevates risks of hypoglycemic episodes. Current literature and many 
practicing dieticians suggest the Mediterranean diet as a model diet for diabetic patients [61]. A 
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recent meta-analysis concluded that low carbohydrate, low glycemic-index, Mediterranean diets 
were effective at reducing HbA1c in T2DM patients [62]. 
 Dietary considerations are not limited to carbohydrate intake, especially if the client 
suffers from or is at risk for developing comorbid conditions such as cardiovascular disease and 
obesity. The consumption of lower levels of sodium and saturated fats, along with increasing 
fibre and micronutrients, is favourable for increasing overall health. This also means avoiding 
most processed foods, including fast food and sugary beverages, which have a strong 
relationship with T2DM development [63,64]. 
 These dietary goals can be difficult to achieve; many patients with T2DM have spent 
many years routinely consuming high sugar-containing foods with low nutritional value, or are 
from ethnic backgrounds where traditional foods (particularly rice or other starchy staples) need 
to be limited to protect the client’s health – an exceedingly difficult lifestyle change to make. It 
has been demonstrated that sugary beverages, high glycemic index foods, fat quality and eating 
patterns all increase the risk of developing T2DM [60]. 
1.3.3 Medication Adherence 
 Various medications target different aspects of T2DM pathophysiology in order to 
normalize serum glucose levels. Metformin is the first-line medication prescribed for T2DM in 
conjunction with lifestyle change, and is sometimes prescribed to patients with pre-diabetes [65] 
as a pre-emptive measure. Metformin is a bigaunide class drug, which prevents the liver from 
metabolizing glucagon and releasing it into the blood stream, as well as increasing insulin sensor 
sensitivity in cellular membranes [66]. Estimates on the effectiveness of metformin are mixed, 
with some studies claiming reduced risk of complications [67] while others indicate 
ineffectiveness [65]. 
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 Another frequently used medication class are sulfonylureas (e.g. glyburide), which 
stimulate pancreatic beta cells to produce more insulin [68]. While effective, this class of drug 
has an increased probability of causing hypoglycaemia if not properly balanced with diet and 
exercise [69]. It should also be noted that the hyper-stimulation of pancreatic beta cells achieved 
with sulfonylureas may further increase the rate of degradation of insulin producing beta cells, 
quickening the onset of exogenous insulin dependency. Other classes of common diabetic drugs 
include alpha-glucosidase inhibitors (e.g. Miglitol) which act in the small intestine to delay the 
absorption of post-prandial glucose and dipeptidyl peptidase-inhibitors (DPP-4) (e.g. Januvia) 
which slows inactivation of incretins that stimulate the pancreas to release insulin. The last of the 
common drugs used to help control serum glucose levels in T2DM patients is the insulin 
hormone itself. Injectable (exogenous) insulin is less a drug and more a supplement of the 
naturally occurring hormone responsible for the uptake of serum glucose by body tissue. As 
T2DM progresses and the pancreas loses its ability to produce insulin, even with the support of 
pharmacological agents, it becomes necessary to supplement with external sources of insulin. 
 Each of the various forms of insulin has precise guidelines that suggest optimal dosage 
times in relation to food intake. Typically, most diabetes drugs (including insulin) must be taken 
with a meal to properly interact with the glucose ingested. Deviations from the optimal dosing 
times decrease drug effectiveness and increase hypoglycaemia risks. Missed medication doses 
are common [70] and more common when patients suffer from depression [71]. The problem of 
missed doses typically assumes the patient has medications to use and either forgets or decides 
not to take it, but recent literature suggests that an astonishing 28.8% of all new diabetes 
prescriptions are never even filled [72]. 
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 The United Kingdom Prospective Diabetes Studies investigated an intensive glucose 
control therapy for newly diagnosed T2DM patients using sulphonylurea class drugs or insulin or 
metformin versus dietary restriction only found significant reductions in HbA1c for the intensive 
intervention group [73] which were persisted after a 10-year follow-up [74], reinforcing the 
importance of pharmacological therapy for the successful management of T2DM. 
1.3.4 Stress Management 
 A significant indicator of quality of life in patients with T2DM is their ability to manage 
stress [48], as perceived stress is an important long-term predictor of T2DM progression [75,76] 
and the development of adipose tissue [77]. Cortisol, secreted by the adrenal gland under stress 
conditions has been demonstrated to interfere with insulin action [78], and work-related stress, in 
particular, has a demonstrated link with T2DM onset [76]. Living with diabetes, and trying to 
incorporate many of the lifestyle modifications that have evidential support, while balancing the 
responsibilities of everyday life like going to work and raising children can be overwhelming for 
many people [19]. Services provided by clinical psychologists can be expensive and are likely 
inaccessible for many people with T2DM; finding lower cost, more accessible strategies for 
stress management is preferable. 
 Mindfulness meditation is an ancient technique that has gained academic and clinical 
recognition for its scientifically supported health benefits which include decreased cortisol levels 
[79,80], increased grey matter density in the brain [81], reduction of negative automatic thoughts 
[82] and general stress reduction [83]. Mindfulness meditation is the practice of paying attention, 
on purpose while practicing non-avoidant cognitive-emotional processing and equanimity [84] 
and has been demonstrated to lower cortisol levels in T2DM patients and helps reduce HbA1c 
levels [83,85]. 
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1.3.5 Symptom Monitoring 
 Optimal management of T2DM revolves around glucose control, with an ideal serum 
glucose range typically 4-7mmol/L, with fluctuations after meals [30]. Amidst the natural 
fluctuations in T2DM, the range typically depends on disease severity, diet, activity levels, stress 
and medication dosing. Patients can manually check their blood sugar by analyzing a fingertip 
blood sample with a portable glucometer, and this is preferably done several times per day. 
Although necessary, it can be painful, inconvenient, and expensive. Although glucometers are 
usually provided free of charge, a single-use test strip for each assessment is typically priced 
between $0.85-$1.00 CAD, which becomes problematic for poorer patients for whom an extra 
few dollars a day is significantly challenging or impossible. 
While extreme blood sugar readings, such as < 4mmol/L and > 18mmol/L can have 
noticeable cognitive and physical consequences, many patients may not notice major sugar 
fluctuations until more severe symptoms set in. Nonetheless, it is important for good diabetes 
management that a patient check their blood glucose multiple times daily, preferably upon 
waking, pre-prandial, two hours postprandial, pre and post exercise, and before going to sleep 
[86]. Frequent checking has been shown to improve glycemic control [87], although the best 
improvements in management are found when monitoring is paired with education and clinical 
support [88]. 
 In addition to checking serum glucose levels throughout the day, it is important for 
patients to have regularly scheduled lab blood tests to assess their overall glucose management. 
As previously mentioned, glycation is the process of glucose molecules attaching to body tissues, 
which cause micro and macro-vascular damage over time with T2DM [31]. The glycation of red 
blood cells (measured by HbA1c) is a measure of the damage to red blood cells over a period of 
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2-3 months and has been shown to be strongly correlated with serum glucose management and 
the onset of diabetes complications [31,89].  Alarmingly, a recent investigation found >50% of 
Canadians with T2DM do not have their HbA1c tested at least once a year [90]. 
 
1.4 HEALTH COACHING 
1.4.1 Previous Literature 
The evidence in support of the importance of healthy lifestyles for chronic disease 
prevention and management illustrates the need for behaviourally-focused interventions, as 
health education alone is apparently insufficient [91]. Health coaching (HC) has gained 
momentum in the literature as a potentially effective means of supporting clients to adopt and 
adhere to health related goals relevant to improving outcomes from a variety of chronic disease 
states [92]. Health coaches specialize in behaviour change methods that assist clients to adopt 
healthy behaviours, overcome resistance and resolve ambivalence to achieve optimum health. A 
recent meta-analysis found the number of peer reviewed articles investigating health coaching 
has increased from only 22 articles published before 2003, to 152 articles published between 
2010 and 2012 [93].  
 While a recent feasibility study suggests that providers and patients at Family Health 
Teams and Community Health Centres in Ontario would welcome health coaching as an added 
service for their patients [94], health coach program delivery focusing on T2DM management 
varies significantly across the literature, with intensity of health coach interaction, professional 
credentials of health coaches, and behaviour change-specific training health coaches receive all 
approached differently across studies. In this context, intensity refers to the frequency and 
duration of each session/interaction. In theory, the intensity of health coach interactions should 
have a linear relationship with outcomes, as continued support will help manage relapse and 
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adherence. However, titration of intensity to find the optimal levels is necessary since intensity is 
directly related to intervention cost, yet without adequate intensity, health-coaching interventions 
run the risk of being ineffective. 
 Health provider administered health coaching has been tested with a range of strategies 
and clinical diabetes outcomes. A recent cluster-RCT evaluated telephonic health coaching 
provided by general practitioner nurses in 59 general practices in Victoria, Australia focused on 
poorly managed T2DM patients [95]. Based on two days of training from a general practice 
nurse, health coaches delivered a median of four coaching sessions/participant over 18 months, 
averaging 30 min/session and focused primarily on increasing medication adherence, lifestyle 
modification and symptom monitoring [96]. Results showed no significant differences between 
intervention and usual care control group in the assessed outcome variables (HbA1c, lipid 
profile, weight, Diabetes Self-Efficacy Scale, Assessment of Quality of Life Instrument, and the 
Patient Health Questionnaire-9) [95]. 
 Another trial conducted by general practice nurses investigated the effect of five sessions 
of telephone coaching over a 6-month period to a control group in poorly controlled, low SES, 
T2DM patents (n=201). The control group received a 20-page educational brochure at study 
initiation. No significant differences were found in outcome variables (HbA1c, lipid profile) 
between intervention and control groups, and the investigators concluded a more intensive 
intervention was required [97]. In another trial with a telephone based coaching protocol, 
participants received up to 10 calls (4- to 6-week intervals) over a 1-year intervention with 
nurses as the health coaches and were compared with a print-only group who received regular 
mailings of diabetes health promotion materials. While both groups received the printed 
materials, only the health coach group was prompted to use them. While an effect was observed 
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suggesting that the receipt of more calls led to greater gluco-regulation improvements, 
intervention group participants had a mean HBA1c reduction of 0.23±0.11% while the active 
control group slightly increased by 0.13±0.13%(p=.04) [98]. Nashita et al. [99] intervened with a 
group of T2DM patients (HbA1c ≥ 6.5%; employed at least 10 hours per week) by pairing them 
with a ‘life coach’ and pharmacist who supported adherence to self-determined goals. Coach and 
participants met an average of 10 sessions for 60 minutes/session over the intervention period 
(12 months), and pharmacists met with participants a mean of 4 times over the intervention 
period for about 45 minutes per session. Coaches received training in the International Coach 
Federation core competencies, and on diabetes self-management strategies from a registered 
nurse. In total, coaches received 65 hours of training based on the International Coaching 
Federation core competencies including rapport building, active listening and goal setting [100], 
prior to seeing participants. Coaches received continuing training by meeting with a certified life 
coach periodically throughout the intervention. The comparison group was a care as usual 
control group. No between-group differences were detected for HbA1c (p=.24) (and no change 
within groups), although between-group differences were detected for diabetes self-efficacy 
(p=.002), BMI (p=.004) and quality of life (p=.01) [99]. 
 Ruggiero et al. [101] conducted a large RCT (n=270) targeting patients from visible 
minority/lower SES communities with T2DM (HbA1c ≥ 6.5%). In this trial, medical assistant 
coaches provided face-to-face (30min) and phone calls interactions (15min) over 6-months 
compared with a care as usual control group. In-person coaching sessions occurred twice, once at 
study commencement, and the second at three months, following their physician appointment. 
Telephone sessions were done during months 1 - 5 between in-person session visits, and when 
patients missed their appointments. Investigators found no significant differences between 
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groups over 12 months. Medical assistant coaches received training from the study PI and/or 
project manager on topics ranging from diabetes self-management, epidemiology, risk factors, 
complications and medications, behavioral counselling strategies based on the trans-theoretical 
model of behaviour change, motivational interviewing and a structured coaching protocol. 
Results indicated no differences in HbA1c between or within groups from baseline to 6 or 12-
month follow-up [101]. 
 Varney et al. [102] conducted another 12-month health coaching RCT (n=94) with 
registered dieticians as health coaches and patients from an outpatient Diabetes Clinic at St. 
Vincent’s Hospital, Melbourne. Intervention participants received 6 telephone coaching sessions 
(45 minutes for the initial session, 20 minutes each follow-up session) that focused mainly on 
diet, and also discussed appropriate physical activity, medication adherence, foot screening, etc., 
while the control group received care as usual. The type and duration of counselling specific 
training was not included in study methods. Results indicated a difference in reduction of 
HbA1c, fasting glucose and diastolic blood pressure between groups at 6-months, but these 
changes disappeared by 12-months. Within-group changes were not presented. Overall, the study 
authors suggest that telephone coaching can be effective at maintaining adherence to health 
behaviours for patients attending outpatients diabetes care, but new strategies must be developed 
to ensure long-term adherence [102]. 
The largest coaching and lifestyle modification intervention investigating lifestyle 
modification for the prevention of T2DM was the Diabetes Prevention Program [103]. In this 
trial, 3234 non-diabetic patients with elevated fasting and post load (IGTT) glucose levels were 
randomized to either metformin (850 mg twice daily) and an intensive lifestyle modification 
program supervised by a case manager, or usual lifestyle recommendations with placebo tablets 
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ingested twice daily. Participants in the intensive lifestyle intervention arm met with a case 
manager on a one-on-one basis and received a 16-lesson curriculum during the first 24 weeks of 
the trial covering diet, exercise and behaviour change focused on achieving participant goals. 
The curriculum was delivered in a personalized and culturally sensitive manner. After the initial 
16 session after enrolment, participants met with case managers via monthly in-group sessions 
which acted as reinforcement for the behaviour change curriculum [104]. Participants aimed to 
achieve a 7% reduction in baseline body weight by accumulating the recommended 150 minutes 
of physical activity per week, and by maintaining a healthy, low calorie, low fat diet. Results 
indicated that 50% of the lifestyle modification group was able to achieve the 7% body weight 
reduction. Incidence of T2DM was reduced by 58%, 95% CI [48, 66%] and 31%, 95% CI [17, 
43%] in the life-style intervention and metformin groups respectively, compared with control. 
Comparing the two intervention groups, the life-style intervention group resulted in a 39% lower 
incidence of T2DM than the metformin group, 95% CI [24, 51%] [103]. 
Trials that report more successful outcomes for diabetic patients usually employ a more 
intensive health coach protocol. In a cluster RCT, Quinn et al. [105] compared four intensity 
levels of health coach based support using an internet-based communication tool and found 
significant reductions in HbA1c when comparing usual care with the most intense intervention 
level (p<0.001). This system relied primarily on automatically generated messages, prompted by 
patient entries (e.g., self-assessed blood glucose) and excluded any individuals from lower SES 
[105]. Usual care was compared with three intensities of intervention including: (1) coaching 
only, (2) coaching with electronic support, and (3) coaching with electronic support and an 
automatic decision support system. Although telephone communication with their health coach 
was, on average, the same one contact per month, participants also received multiple automated 
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messages per day, which were customized by the health coach. This trial reported significant 
HbA1c reduction differences between the most intensive study arm versus the control group of 
1.9%, with the coach-only arm still demonstrating quite impressive reductions in HbA1c of 1.6% 
[105]. This trial also demonstrated older patients were just as likely to benefit from and use the 
electronic system, reducing their HbA1c by 1.8%, 95% CI [1.1, 2.4] in the intervention group 
and 0.3%, 95% CI [-0.3, 0.9] in the control group [106] which contradicts a common perception 
that older adults will not adopt mHealth interventions [107]. Another secondary analysis from 
this trial suggests that the modification and intensification of antihyperglycemic medications was 
not significantly different for the mHealth group versus care as usual control group [108]. 
Another trial trained dental professionals as health coaches and intervened with T2DM 
patients in Istabul, Turkey [109]. Investigators reported 5-6 in-person coaching sessions, with 4 
telephone sessions over a 10-month period, supplemented by meetings with dieticians and nurses 
at an undisclosed frequency. Results demonstrated a 0.6% reduction in HbA1c and no change for 
the care as usual health education control group at the 16-month follow-up, after a 6-month 
period following intervention termination [109]. 
Another group of researchers from the Faculty of Medicine in the University of Oslo, 
Norway recently tested the use of a mobile phone–based self-management system with and 
without telephone health coaching support in improving HbA1c level, self-management, and 
health related quality of life compared with usual care. Study participation was open to 
individuals with T2DM who had an HbA1c ≥7.1% and aged ≥18 years. Both intervention groups 
had access to a mobile phone–based self-management system called “Few Touch Application” 
which enabled users to track blood glucose, diet, physical activity, and personal goals. One 
intervention group received health coaching delivered by a diabetes specialist nurse for the first 4 
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months of the 12 month intervention [110]. Data at follow-up was available for 120 participants 
(79%) and indicated that there was no significant difference between HbA1c for control and 
either of the intervention groups (p=.57/.97). HbA1c reductions within groups were also non-
significant with modest effect sizes ranging from -0.31%, 95% CI [–0.67, 0.05] for the app only 
group, -0.16%, 95% CI [-.58, 0.29] for app with health coaching, and -0.15%, 95% CI [-0.5, 
0.18] for control participants [110]. 
Peer health coaching is another model of health coach intervention delivery that promises 
even lower costs due to the potentially reduced need for less professional intervention. A group 
from the University of California, San Francisco, Grorob et al. [111] tested the efficacy of 
training and employing peer health coaching with a lower SES T2DM population. After peer 
coaches received 36 hours of training over an eight-week period, their skills were examined, and 
they were provided $150 for attending and $25/month/patient coached over a six-month period. 
In this trial, coaches and patients interacted at least twice a month either in person or over the 
phone (at the discretion of the coach and patients) and were required to meet at least twice in 
person during the 6-month intervention. Results indicated a 1.0% drop in HbA1c in the coaching 
arm and a 0.3% drop in the care as usual control arm demonstrating a significant effect [112]. 
 
1.4.2 Defining Health Coaching 
 Academic and clinical communities have not yet reached final consensus on a formal 
definition of a health coach. Therefore, existing studies that claim to evaluate health coaching 
interventions use a variety of working definitions, although all follow a similar emphasis on 
behaviour change. For example, some researchers use the following definition: 
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“Health coaching is the practice of health education and health promotion within a 
coaching context, to enhance the wellbeing of individuals and to facilitate the 
achievement of their health-related goals” [92,113]. 
 
Others define it this way: 
“…a behavioural health intervention that facilitates participants in establishing and 
attaining health-promoting goals in order to change lifestyle-related behaviours, 
with the intent of reducing health risks, improving self-management of chronic 
conditions and increasing health-related quality of life” [114,115]  
 
Recently, the National Consortium for Credentialing Health and Wellness Coaches, a 
conglomeration of several researchers pursuing health coaching evaluation define health coaches 
as: 
“…professionals from diverse backgrounds and education who work with 
individuals and groups in a client-centered process to facilitate and empower the 
client to achieve self-determined goals related to health and wellness.” [116]. 
 
As the research matures, and health coaching becomes more commonplace among medical and 
academic communities, the need of a universal, operational definition may decrease in relevance 
as the purpose and efficacy of different subtypes of health coaches become more understood. 
From our point of view, a health coach is defined as: 
“A behaviour-change counselling specialist with expertise in chronic disease 
management and evidence-based theory adapted for disease state, SES, and ethno-
cultural backgrounds”. 
 
 
1.4.3 Health Coach Training and Credentialing 
Another issue concerns the credentialing and educational background of the individual 
providing the health coaching services. This concern has two distinct components that must be 
considered: 1) the depth and duration of training in behaviour change theory and the supervised 
practice coaches receive; 2) their professional designation and/or liability insurance coverage. 
When engaging with a client in behaviour change counselling with a chronic health condition 
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like T2DM or CVD, there is a risk, however small, of the occurrence of an adverse event such as 
a heart attack, injury or even death. Professional designation and membership to a regulated 
college provides the health coach with the necessary protection and accountability to provide 
care while protecting the client. 
In regards to the training, a recent literature review found that only 22% published health 
coach intervention studies discuss the training health coaches receive [93]. Training for health 
coaches is typically focused on Motivational Interviewing (42% of studies) and the trans-
theoretical model of behaviour change (60.8% of studies), while the length of training varied 
widely among trials, ranging from just two hours to as much as two hundred hours [93]. 
Among trials that required professional designations for coaches, studies have employed 
individuals with a masters in psychology [117], certified medical assistants [118], registered 
nurses [95,96,119], physiotherapists [119], and peer health coaches [120]. Despite the spectrum 
of professional designation of the health coach, most literature discusses the core competencies 
of a health coach, suggesting the skills can be taught to any health care provider. 
1.4.4 Health Coaching Skills 
The health coach is a specialist in behaviour change, and the process of behaviour change 
can be approached using a variety of evidence-based techniques. Relying solely on a single 
technique runs the risk that the health coach becomes philosophically fixed in a behaviour 
change paradigm that does not serve the needs of a particular client, leading to tension in the 
therapeutic relationship. A broad set of methods can help coaches understand the complexities of 
health behaviour, and contextualize the client’s behaviour in a more nuanced way. This can in 
turn help prevent coaches from viewing a failure to make desired changes as an indicator of a 
‘bad patient’ and reduce provider frustration. For example, a 2005 study by Wens et al. asked 
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physicians about how they dealt with the typically poor adherence to prescribed treatments 
demonstrated by their patients with T2DM. The physicians described intense frustration with the 
lack of lifestyle changes made by their patients, which led to a paternalistic attitude towards 
patient communication, attempts to shock or pressure the patients into making changes, or to 
refer them to hospital care. The authors believed a lack of communication skills and training was 
a major factor hindering care in this situation [121]. Using an integrative health coaching model 
to provide holistic care, addressing multiple lifestyle, social, psychological and medical factors is 
one way to assist healthcare providers in bridging this communication gap with their patients. 
The approach to health coaching that maximizes the probability of successful interaction 
must be open to any of the evidence-based techniques that demonstrate effective behaviour 
change outcomes. Within the health coach literature, groups typically commit to only one 
technique, with the most common evidence-based behaviour change technique being 
Motivational Interviewing (MI) [115,122]. MI involves strategies for engaging in conversation 
with clients to encourage ‘change talk’, overcoming resistance to behaviour change and 
developing strategies for sustainable positive behaviours [122]. For example, an important part 
of MI is ‘rolling with resistance’. This is the process of conversing about states of relapse and an 
individual’s resistance to changing important behaviours while not directly confronting the 
client, in an effort to reduce psychological reactance [123]. Occasionally, rolling with resistance 
can be problematic when it fails to generate change over a long period of time.  
When a more direct approach is needed when working with a given client, Cognitive 
Behavioural Therapy (CBT) is a useful tool. Traditionally used to assist with problematic 
psychological states such as depression and anxiety, CBT has recently demonstrated efficacy in 
health behaviour change programs working with patients with poorly controlled T2DM [124] 
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and metabolic syndrome [125]. CBT is based on a theoretical model that connects a person’s 
thoughts, emotions, and behaviours in an interconnected matrix. Using a CBT framework, 
coaches engage in a systematic approach to assist their client(s) become aware of these 
connections and adapt specific activities and strategies to change them [126]. Other tools within 
the health coach arsenal may include Acceptance Commitment Therapy (ACT), Interpersonal 
Therapy (IT) and Emotion Focused Therapy (EFT) [125]. All of these approaches can be 
effective at supporting the behaviour change process when the health coach is open to their use. 
Across all techniques, the most important commonality is that a strong therapeutic alliance with 
the client must be developed and sustained, nurturing a deep level of trust. Only once the 
therapeutic alliance has been established will the adaptation of whatever technique is most suited 
for that client be effective [127].  
 
1.5 ELECTRONIC CONNECTIVITY 
1.5.1 Mobile Technology 
 Mobile technology has permeated Western culture to a point of intense saturation with 
27,863,660 Canadian cellular subscribers in 2014, accounting for ~80% of the population [128], 
indicating the vast majority of Canadians have access to instant communication in both mobile 
voice and text mediums. Smartphones with internet connectivity provide access to email, news, 
social media, cloud storage, search, and an expanding library of downloadable applications and 
multiple methods of real-time communication. Current estimates put smartphone market 
saturation at ~56% of Canadians [129]. 
In the context of health, a high number of mobile applications (apps) are available for 
download in the online market that enable users to track health and fitness indicators such as 
weight, exercise, sleep, diet, calories, steps, heart rate, and distance travelled. Compared with 
27 
paper and pen tracking methods, mobile health apps excel in immediacy and accuracy for real 
time self-reporting and tracking of health information [130].  
1.5.2 Health Apps 
Many health apps provide users sophisticated feedback and detailed information on 
exercise bouts. For example, Adidas MiCoach (http://micoach.adidas.com/ca/) uses the Global 
Positioning System (GPS) to track users while they walk/run/bike and to generate reports of 
average speed, distance, and pace. Apps with similar characteristics can also connect users to 
social networks and share health-related accomplishments with friends and family, using social 
support to help reinforce these healthy behaviours. The app Strava (http://www.strava.com/), for 
example, not only uses GPS to track users while they run or bike, but also compares one user’s 
performance with others who have navigated the same stretch of road, adding a competitive 
ranking system that some users may find motivational, although no research in this area has been 
completed to date. 
There are also apps that more intensively focus on diet, such as MyFitnessPal 
(www.myfitnesspal.com). MyFitnessPal is one of a cluster of apps that maintain a food 
information database that provides users who wish to keep track of the specific food they eat to 
know exactly how many micro-and-macronutrients they consume. This can be extremely 
valuable for users attempting to reach specific goals, such as losing weight or reducing sodium 
intake to better control hypertension. A recent RCT found that MyFitnessPal use demonstrated 
only modest reductions in weight, with no differences between controls (who were not 
encouraged to download the app) and intervention groups (who were specifically asked to 
download and use the app). While it was noted that some control participants did downloaded the 
MyFitnessPal app (13%), there were a significant loss of subjects at followup (32% of the 
intervention group was assessed while 19% of the control group) and although reported 
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satisfaction with the app was apparently high, use of the app decreased sharply after the first 
month of the trial [131]. In line with research into other app-based health interventions, without a 
real person (e.g. health coach) to support software use, outcomes reflect modest or no significant 
between-group or within-group differences [110]. 
1.5.3 Wearable Technology 
A new area in mobile health that has been growing aggressively is the market for 
wearable technology. Connecting via Bluetooth, a wireless communication technology standard 
on nearly all mobile devices (www.bluetooth.com), external peripherals link seamlessly to 
phones with a fast, wireless connection. This has resulted in a wide variety of personal health 
monitoring devices developed with the specific intention of connecting with health tracking 
apps. Examples of popular Bluetooth health devices include pedometers and accelerometers (e.g. 
Fitbit, Jawbone Up), heart rate monitors (Polar, Garmin), and weight scales (Fitbit, Aria). The 
research validating these commercially available products is, however, in its infancy. Fitbit 
devices alone have been subject to investigative reports providing evidence of accuracy in 
counting steps [132], but an underestimation of energy expenditures and tenuous measurement of 
sleep quality [133]. The next generation of Bluetooth health technology that is still not widely 
distributed includes smart watches (Pebble, Apple iWatch, Samsung Gear), glucometers 
(OneTouch Verio), sleep trackers (Body Media, Fitbit), blood pressure cuffs (iHealth, Withings), 
pulse oximeters (iHealth), EEG recorders (Muse), ECG recorders (Alive Technologies, Texas 
Instruments) and smart shirts capable of a number of measurements (Om Signal Biometric 
Smartwear, Underarmour E39). These technologies have the potential to radically change how 
medicine is practiced by integrating continuous, non-burdensome medical evaluation outside the 
clinic and within the daily life-schedules of patients. The potential for a heart failure patient to 
have a 24-hour ECG lead transmitting heart rhythm in real time with a monitoring system that 
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can identify abnormalities before they become symptomatic, and warn the patient and contact 
emergency medical services is a real possibility. This type of device could simultaneously be 
able to communicate directly with medical practitioners and/or family members. 
1.5.4 Clinical/Medical Integration 
Despite the popularity and potential of health apps, the medical community has yet to 
embrace mobile technology in practice. These types of technologies are still mainly in the 
research phase of implementation, with new insights being published every month. The switch 
from research to clinical practice is imminent, as the latest findings suggest that when patients 
track health measures electronically and share the information with providers, the quality of their 
health care increases [134]. There have been concerns that some populations (namely older 
adults) may have difficulty using newer technology [135].  Although recent clinical trials 
indicate that the learning curve for initiating app use may be greater when compared to younger 
populations, there are no effects on outcomes that appear to be grossly mitigated by age [106]. 
Technology provides the health coach an immediate and cost effective way to maintain 
consistent interaction with clients, even when not in direct contact within the clinical 
environment [136]. In the literature, apps have been used to support behaviour change for 
individuals with chronic disease, and it has been discussed that although they can be a powerful 
facilitator of health behaviour, apps and wearable devices are not necessarily motivators behind 
sustained behaviour change [137]. The best combination may be some combination of 
personalized interaction by a health coach with the strategic use of smart phone applications. 
 
1.6 CONCLUSION 
The literature suggesting the importance of the regular engagement in positive health 
behaviours for individuals with T2DM illustrates a decisive need for behavior-focused 
interventions. This dissertation seeks to test the combination of health coaching with the use of a 
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web-portal that provides two-way communication and behaviour tracking/monitoring for poorly 
managing T2DM patients from a lower SES community. We first determined the feasibility of 
this research in a pilot trial where we assisted with the mobile-phone app development and 
created health-coaching protocol and applied both to patients at the Black Creek Community 
Health Centre (BCCHC). Then, in a larger RCT, we sought to compare health coaching with and 
without app connectivity in improving gluco-regulation and psychological well being among 
T2DM patients.  
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CHAPTER 2: MEASURES INCLUDED IN DISSERTATION 
 
2.1 GLYCATED HEMAGLOBIN 
The primary outcome variable for this dissertation is the change in glycated hemoglobin 
(HbA1c) from baseline to 6-months. Glycation is the process of the non-enzymatic attachment of 
glucose to body tissues as a result of chronic hyperglycemia [29]. HbA1c is a clinical tool that 
accurately represents overall glucose management in diabetic patients and is a strong predictor of 
diabetic complications [31]. While glucoregulation can be evaluated using three types of tests 
(fasting plasma glucose, the oral glucose tolerance test, and HbA1c), HbA1c especially useful as 
it provides an excellent clinical indicator of gluco-regulation over a three-month period since red 
blood cells are renewed every three months. HbA1c is often thought of as an ‘average’ blood 
glucose reading to patients and, although this is not technically correct, it does provide a 
summary measure. HbA1c is also used as a diagnostic tool for T2DM, where a value of 6.5% 
indicates sufficiently high glycation to warrant the diagnosis [30] (healthy range is 4.5%-5.7%). 
The clinical target for HbA1c with diagnosed patients is 7.0%, although lower values are 
preferred, and unfortunately many patients have HbA1c levels that range as high as 13%. 
Pharmacological and other clinical interventions typically aim for reductions of 0.5% HbA1c to 
be considered clinically relevant [138]. Although an HbA1c of less than 6.0% can be difficult to 
achieve with diagnosed T2DM, it is possible through medication adherence, regular exercise and 
a carbohydrate restricted diet [32].  
 
2.2 ANTHROPOMETRIC ASSESSMENTS 
Three measures of anthropometric or body composition associated with health-related 
fitness were collected and used as secondary outcomes. These measures include: body mass 
index (BMI), waist circumference (WC), and weight (kg). BMI was calculated using the 
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participant’s weight and height (BMI=weight (kg)/height (m2)). WC was measured using a tape 
measure according to guidelines identified by the Canadian Diabetes Association [30] (align 
bottom edge of tape with the top of the hip bone and wrap the tape all the way around the waist 
ensuring it remains parallel with the floor. Measurements were taken to the nearest 0.5 cm. 
T2DM is highly correlated with excess body weight and BMI in such that some literature 
suggests obesity playing a causal role in insulin resistance [139]. 
 
2.3 PSYCHOMETRIC ASSESSMENTS  
2.3.1 Satisfaction with Life Scale 
The Satisfaction with Life Scale (SWLS) (Appendix B1) is a five item self-report 
measure developed to assess an individual’s global satisfaction with life as a cognitive 
judgement and has shown high internal consistency and temporal reliability [140]. Participants 
respond to questions such as: “In most ways my life is close to my ideal” and “So far I have 
gotten the important things I want in life”.  Each item is measured on the following seven-point 
Likert scale: (1) strongly disagree, (2) disagree, (3) slightly disagree, (4) neither agree or 
disagree, (5) slightly agree, (6) agree, (7) strongly agree. The seven items are summed to achieve 
a total score of 5-35 which are categorized into: scores from 5-9 indicating extreme 
dissatisfaction with life; 10-14 indicate dissatisfaction with life; scores from 15-19 show below 
average in life satisfaction; 20-24 indicates average satisfaction with life; 25-29 indicates high 
satisfaction with life; and scores from 30-35 represent extreme satisfaction with life. 
2.3.2 Hospital Anxiety and Depression Scale 
The Hospital Anxiety and Depression Scale (HADS) (Appendix B2) is a 14-item 
questionnaire designed to be easily administered (taking between 2-5 minutes to complete) and 
able to distinguish emotional or mood disorders that would have the most clinical relevance for 
treatment considerations, specifically anxiety and depression [141]. In an effort to capture the 
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most useful underlying experience of the depressive experience, authors used the state of 
anhedonia, which is the inability to experience a pleasurable response to a given situation. 
Participants were asked to respond to statements such as “I no longer get pleasure from the 
things I normally enjoy” and “I have lost interest in my appearance” as well as items framed 
positively, for example: “I feel cheerful” and “I can laugh and see the funny side of things”. 
Participants respond by underlining the response that most accurately reflects their feelings over 
the past week out of four options. Examples of possible responses are: (1) Definitely as much, 
(2) Not quite so much, (3) Only a little, (4) Hardly at all. Responses are scored between 0-21 for 
anxiety and 0-21 for depression. A score of 0-7 is considered with ‘normal’ range, a score higher 
than 11 indicating probable presence of the mood disorder, and a score of 8 to 10 being 
suggestive of the mood disorder. 
2.3.3 Positive and Negative Affect Schedule 
The Positive and Negative Affect Schedule (PANAS) (Appendix B3) is a 20-item scale 
with 10 positive and 10 negative descriptors developed to provide separate indicators of positive 
affect (PA) and negative affect (NA) [142]. PA is defined to the degree one experiences the 
activation of positive valenced affects or pleasurable interactions with the environment, while 
NA is an indication of the extent one experiences negative valenced effects or subjective distress 
and unpleasurable engagement [143]. Participants are asked to indicate how they were feeling at 
the current moment by providing a response next to words that corresponded to either PA (e.g. 
strong, confident, excited) or NA (e.g. incompetent, fearful, ashamed). Possible responses were: 
(1) very slightly or not at all, (2) a little, (3) moderately, (4) quite a bit, (5) extremely. 
Respondents are measured independently per subscale resulting in a separate score for PA and 
NA, with scores of each subscale ranging from 10-50. The internal consistency is high for both 
subscales, with Cronbach’s alpha ranging from .86 to .90 for PA, and from .84 to .87 for NA 
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[142,143]. NA and PA scales have shown to have a poor correlation (r = -0.12) [142], indicating 
that these subscales measure distinctive constructs and should not necessarily be considered to be 
inversely proportional to one another.  
2.3.4 Short Form Health Survey-12 (Version 2) 
The Short Form Health Survey-12 Version 2 (SF-12v2) (Appendix B4) is a widely used 
health related quality of life measure that is used to predict functioning level, health care 
utilization and health outcomes [144]. Mental and Physical Health composite scores of the SF-
12v2 are calculated from twelve items, which were derived from the larger SF-12 and improved 
upon from the original SF-12 in 2002 [145]. Participants are asked if, and to what extent, aspects 
of their life have been interrupted by health issues. For example, participants are asked “In 
general, would you say your health is:” and “During the past 4 weeks, how much of the time 
have you had any of the following problems with your work or other regular daily activities as a 
result of your physical/mental health?”. Participants respond with either a three or five point 
Likert scale tailored to the question. The twelve items of the SF-12 are derived from a larger 
questionnaire, the SF-36, and has demonstrated excellent comparative validity [146,147]. The 
SF-12 has demonstrated excellent test-retest reliability in determining health status been used on 
a wide number of populations including HIV patients [148], older adults [149], trauma 
populations [146], and stroke victims [150] among others. As well, the SF-12 scoring algorithm 
utilizes norm based scoring, which compares the responses of any participant with that of a 
normative sample of the US population collected in 2009 (mean=50, SD=10) [145]. 
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3.1 RATIONALE FOR STUDY #1 
3.1.1 Objectives 
 The intent of the study was to develop and test a smartphone-assisted intervention that 
improves behavioral management of type 2 diabetes in an ethnically diverse, lower SES 
population within an urban community health setting. 
3.1.2 Hypotheses 
Participants will be receptive to the health coaching with remote connectivity 
intervention, and will achieve significant clinical improvement in glucose management, as 
indicated by reductions in HbA1c of greater than 0.5% (6 mmol/mol). 
 
3.2 ABSTRACT 
Background: Lower socioeconomic strata (SES) populations have higher chronic disease risks. 
Smartphone-based interventions can support adoption of health behaviors that can, in turn, 
reduce the risks of type 2 diabetes-related complications, overcoming the obstacles that some 
patients may have with regular clinical contacts (eg, shiftwork, travel difficulties, 
miscommunication). 
Objective: The intent of the study was to develop and test a smartphone-assisted intervention 
that improves behavioral management of type 2 diabetes in an ethnically diverse, lower SES 
population within an urban community health setting. 
Methods: This single-arm pilot study assessed a smartphone application developed with 
investigator assistance and delivered by health coaches. Participants were recruited from the 
Black Creek Community Health Centre in Toronto, and had minimal prior experience with 
smartphones.  
Results: A total of 21 subjects consented and 19 participants completed the 6 month trial; 12 had 
baseline glycosylated hemoglobin (HbA1c) levels >7.0% and these subjects demonstrated a 
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mean reduction of 0.43 (0.63) (p<.05) with minimal changes in medication.  
Conclusions: This project supported the feasibility of smartphone-based health coaching for 
individuals from lower SES with minimal prior smartphone experience.  
 
 
 
3.3 INTRODUCTION 
3.3.1 Background 
  A consensus of medical professionals and academic researchers indicates that type 2 
diabetes mellitus (T2DM) is a chronic condition that progresses to more debilitating 
complications if certain unhealthy behaviors persist [30]. Regular exercise conversely prevents 
deteriorating health and disease onset [151] and has measurable benefits for T2DM-diagnosed 
populations [53,152]. Because high carbohydrate diets increase risks for diabetes-related 
complications due to chronic hyperglycemia, dietary modification can also result in risk 
reductions [153]. The adoption of optimal health behaviors in those diagnosed with T2DM 
requires behavior change and support for diabetic individuals from lower socioeconomic strata 
(SES) is especially important as this population confronts additional challenges in maintaining 
good health [19]. Data from the Canadian Healthy Community Survey (2005) suggest 
individuals from the lowest income group are over 4 times more likely to have T2DM [13]. 
Furthermore, education and personal wealth variables, typically viewed as SES proxies, are the 
strongest predictors of premature death associated with T2DM [12]. Despite recent surges of 
interest in disease incidence related to SES, little attention has been paid to urban, low SES 
immigrant/minority groups. As our experience indicates, these individuals are often less willing 
to volunteer for research and are less reliable subjects after enrollment. This is mainly related to 
the competing demands they confront and the lack of flexibility in their working conditions.  
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  Health coaches promote adoption and maintenance of health behaviors, using validated 
theoretical frameworks (eg, Motivational Interviewing [122] and Cognitive Behavioral Therapy 
[126]). Health coaches primarily focus on helping patients define and attain personal goals and 
discover intrinsic health-oriented motivations [154]. Recent trials involving health coaching in 
chronic disease demonstrate positive gains for patients such as increased exercise and medication 
adherence [117,154], improved psychological functioning [154], and more positive illness-
coping strategies [154]. 
  Mobile technologies complement health coaching by enabling patients and coaches to 
maintain multiple channels of contact via remote monitoring, voice, and text message 
communications. The use of mobile phones potentially provides unprecedented precision in 
supporting health-related behavior since it facilitates responses to immediate needs and serves to 
maintain communication consistency. Once an individual agrees on the intensity, frequency, and 
duration of contacts with the health coach, it is possible to detect non-adherence lapses quickly to 
the point where supportive-corrective responses can be provided while the non-adherent pattern 
is still unfolding. Reminder and reinforcement messages of different types can be sent to patients 
at any hour of day or evening, enabling interactions that purposefully blend with the patient’s 
daily lifestyle. 
  Remote monitoring has been associated in numerous controlled studies with significant 
benefits in improving blood pressure and blood glucose regulation [155–158], exercise 
adherence [159], and dietary control [160,161]. Mobile technologies enable immediate and 
inexpensive communication with patients exemplified in the use of text messages (SMS) to boost 
medication adherence and decrease viral load in HIV-positive Kenyan populations [162], and to 
39 
deliver supportive SMS to patients at risk for developing type 2 diabetes [163], and have 
demonstrated results with a variety of other chronic medical conditions [164]. 
3.3.2 NexJ Connected Health and Wellness Platform (CHWP) 
  The Connected Health and Wellness Platform (CHWP) Health Coach app is designed to 
support multi-channel communications between clients and health coaches, and supportive 
family members. The app was collaboratively designed by software developers (NexJ Systems 
Inc.) and study investigators to support participants in electronically tracking health behaviors 
(eg, exercise, diet, stress reduction practices) and self-monitoring health data (eg, blood glucose, 
blood pressure, mood, pain, energy). Provider-client communications require two-way, 
certificate-based authentication and passwords stored in encrypted columns, with entered data 
recalled by client and health coach through a secure online portal. 
3.4 METHODS 
3.4.1 Study Design 
This experimental pre/post, single-arm trial assessed a 24-week intervention where 
interactions in person, by phone, and by smartphone (eg, secure messaging, email) with a 
personal health coach supported adoption of and adherence to self-generated health-behavior 
change goals. The primary study outcome was glycosylated hemoglobin (HbA1c) assessed at 
baseline and 24 weeks (see Table 2). HbA1c is a clinical indicator of glucose regulation 
correlated with debilitating and costly diabetic complications. The clinical goal for self-
management of diabetes is an HbA1c of 7.0% or less, although further reductions are preferred. 
Interventions that reduce HbA1c in elevated risk populations are of significant value in diabetes 
care. 
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3.4.2 Health Coaching Intervention 
The health coach intervention was carried out by a graduate student trained in behavior 
change techniques. After obtaining informed consent and collecting demographic information 
and baseline lab reports, the participants and the health coach communicated about eating, 
physical activity patterns, and overall health goals. Wellness plans were collaboratively created 
in multiple interactions focused on exercise instruction and reviews of electronic monitoring 
entries, with diet and medication guidelines set by primary care physicians and dieticians. 
3.4.3 Recruitment 
Participants were recruited and consented at the Black Creek Community Health Centre 
in Toronto, Ontario, Canada. Recruitment was through health care provider referral and poster 
advertising. Eligible participants were patients over 18 years old, diagnosed with type 2 diabetes, 
and able to read and speak English. Participants were excluded if their baseline HbA1c was 
greater than 9.5%. All study procedures were approved by the York University Human 
Participants Research Committee and participants provided informed consent. 
3.4.4 NexJ Health Coach App Access 
All clients were given access to the custom smartphone app on a loaned Blackberry 
Curve 8900 with full data access for the duration of the trial (n=19), unless they possessed their 
own Blackberry (n=2), in which case the software was installed on their personal device.  
3.4.5 App Feedback and Development 
Research staff collected participant experience with version 1.0 of the Health Coach app, 
reporting errors and overall feedback. Feedback was organized and relayed back to the software 
design team as described in Figure 1. 
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Figure 1 - Software Improvement Cycle. 
Feedback loop conveys user experience and smartphone software redesign 
 
 
As the Health Coach app was version 1.0, periodic malfunctions hindered client 
communications during the trial. Due to the close relationship between the health coach and 
software production team, the feedback and user experience was communicated as received, 
resulting in upgrades installed on the server at frequent intervals. This feedback loop led to 
significant improvements in the software throughout the trial. Some of the most important 
modifications included user-interface enhancements, general usability, and solution of software 
instability issues. Screenshots of the mobile phone app with an explanation of the various 
trackers and functions are found in Figures 2-11. 
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Figure 2 - Exercise Tracker is designed to easily track 
multiple exercise modalities. Users can capture duration of 
exercise, rate perceived intensity (light, moderate, 
vigorous), and enter additional text comments. 
 
Figure 3 - Food Tracker automatically triggers the 
smartphone’s camera, enabling photo capture of meals. 
Users can subjectively rate food portion, source, and 
healthiness. 
 
Figure 4 - Satisfaction survey: at a customizable timeframe 
(usually 20 minutes), the program prompts for reports on 
satiety level (not enough, just right, too full). 
 
Figure 5 - Blood Glucose Tracker: Clients enter blood 
glucose level and comments on readings. 
 
Figure 6 - Mood Tracker: Clients enter “How They Feel” 
using a simple 5-pt scale: I feel (great, very good, good, 
bad, very bad) and comment on entry. 
 
Figure 7 - Weight Tracker: Clients enter weight and enter 
comments on the reading. 
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Figure 8 - Pain Tracker: Clients can enter subjective pain 
ratings using a 5-pt scale: pain level is (none, mild, 
moderate, severe, very severe). 
 
Figure 9 - Blood Pressure Tracker: Clients enter blood 
pressure including systolic, diastolic, and heart rate and 
are able to comment on the reading. 
 
Figure 10 - Messaging allows for two-way secure messaging 
between participant and health coach who can selectively 
promote healthy choices at pivotal times of client decision-
making, providing support immediately after healthy 
behaviors have been logged, and/or addressing questions 
and/or sending relevant materials. 
 
Figure 11 - Reminders: The trackers use employ alarm-
type entry reminders, which provide convenient ways to 
prompt clients to engage in health behaviors like exercise, 
dietary modifications, stress reduction, and self-reported 
mood. Reminders can be turned on and off easily by health 
coach and/or participant. 
 
3.4.6 Statistical Analysis 
Data was analyzed using SPSS (version 21.0, 2012, IBM, Chicago, IL). Descriptive 
statistics are reported (means and standard deviations). Differences in outcome variables 
(baseline to 24 weeks) were analyzed using a paired samples t test. Participants were split into 
groupings according to baseline assessments (HbA1c≥7.0% and HbA1c<7.0%). Significance 
was set to p<.05. 
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3.5 RESULTS 
Of the 21 participants, final outcome variables were collected for 19. The primary reason 
for missing data was primary care physician failure to forward lab results (n=2). 
Demographics are summarized in Table 1. There was a mean reduction of 0.28% (0.57) 
(p=.05) in HbA1c found over the entire sample. Since participant glucose control varied across 
optimal levels at baseline, data was re-analyzed for those who began the trial with sub-optimally 
managed glucose and those with optimally managed glucose. A total of 12 participants started 
the trial with sub-optimally managed glycemic control (HbA1c≥7.0% [DCCT] or 53 mmol/mol 
[IFCC]) and experienced a greater mean reduction of 0.43% (0.63) (p=.04), while the n=7 
participants who had baseline HbA1c levels within acceptable clinical control range 
(HbA1c<7.0%) had no significant changes in HbA1c at 6 month follow up (0.01, p=.91). 
 
Table 1 - Demographic characteristics at baseline (n=21). 
Characteristic n (%) 
Age (years), mean (SD)  55.6 (12.3) 
Gender 
 Male 9 (43%) 
 Female 12 (57%) 
Marital Status 
 Single 5 (24%) 
 Married or common law 14 (67%) 
 Widowed 2 (10%) 
Children 
 Yes 18 (86%) 
 No 3 (14%) 
Educational Background 
 Less than high school 3 (14%) 
 Completed high school 4 (19%) 
 Some college/university 7 (33%) 
 College diploma 6 (29%) 
 University degree 1 (5%) 
Employment 
 Full-time 12 (57%) 
 Part-time 2 (10%) 
 Not presently employed 7 (33%) 
Ethnicity 
 Hispanic 3 (14%) 
 African 3 (14%) 
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 Caribbean 3 (14%) 
 South Asian 3 (14%) 
 Caucasian 9 (43%) 
 
 
Table 2 - Change in outcomes of patients participating in the health coach intervention. 
  n Baseline, mean (SD) 
Post,  
mean (SD) 
Mean 
change, 
Mean (SD) 
P 
value 
Entire sample 
 HbA1c (%) 19 7.58 (1.13) 7.31 (0.95) −0.28 (0.57) .05 
 Weight (kg) 14 94.6 (16.8) 93.2 (15.8) −1.3 (1.9) .02 
 BMI 13 34.4 (5.5) 33.9 (5.3) −0.4 (0.7) .05 
 Waist Cir. (cm) 11 109.4 (16.1) 112.1 (16.1) 2.7 (4.3) .06 
Baseline A1c ≥7.0% 
 HbA1c (%) 12 8.26 (0.80) 7.83 (0.78) −0.43 (0.63) .04 
 Weight (kg) 9 100.1 (18.0) 98.1 (17.1) −1.9 (1.7) .01 
 BMI 8 36.2 (5.8) 35.6 (5.7) −0.7 (0.7) .04 
 Waist Cir. (cm) 7 114.4 (17.1) 116.5 (16.4) 2.1 (5.3) .33 
Baseline A1c <7.0% 
 HbA1c (%) 7 6.43 (0.39) 6.41 (0.38) −0.01 (0.32) .91 
 Weight (kg) 5 84.6 (8.7) 84.4 (8.8) −0.2 (1.8) .81 
 BMI 5 31.4 (3.7) 31.3 (3.8) −0.1 (0.7) .80 
 Waist Cir. (cm) 4 100.6 (11.0) 104.4 (10.0) 3.8 (1.6) .02 
 
3.6 DISCUSSION 
3.6.1 Principal Results 
In this trial, patients with a range of glucose regulation efficacy were recruited to pilot a 
smartphone-based mobile software application app and personal health coach program and 
demonstrated an overall improvement in HbA1c. Given the objective of demonstrating 
intervention effectiveness for poorly managed diabetic clients, analysis was rerun distinguishing 
poorly controlled from well controlled subjects at baseline (HbA1c>7.0% (53 mmol/mol). 
Participants, who began the trial at a poorly managed level had significant improvements in 
HbA1c and a greater effect than the whole sample, while those who started within an acceptable 
HbA1c range had no improvements, demonstrating the potential clinical relevance of the 
intervention for poorly control diabetic patients  
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3.6.2 Socioeconomic Strata and Intervention Applicability 
  Lower SES populations often have difficulty navigating and accessing the health care 
system [165] to a degree where SES appears to be the best predictor of health status in Canada 
and the United States [166,167], with SES-related factors manifesting as substantial barriers to 
the health of many Canadians. This intervention attempted to address some of these issues by 
engaging participants in a health coaching relationship to overcome accessibility barriers. During 
the course of the intervention, it was observed that participants were sometimes prevented from 
attending appointments with their health care team due to familial obligations and work 
obligations (mainly shift work). With low workplace flexibility, when work had to be interrupted 
to attend a health care session, losing out on the day’s pay was a significant obstacle. The 
intervention reduced this barrier by providing 24-hour electronic access to the health coach, 
enabling participants to initiate communication when possible and convenient. 
  Of our study sample, 34% completed either a college or university degree, compared to 
the 59% of Ontario’s population (and 53% of Canada’s population) who have a university or 
college level designation [168]. Education is a commonly used proxy of socioeconomic strata, 
but educated immigrants to Canada are frequently unable to work in their former disciplines at 
their achieved educational levels due to domestic policies [169]. The intervention demonstrated 
the effectiveness of a personalized, electronically assisted health coaching intervention in an 
underserved population that is not typically the focus of technology-assisted health research. 
Most participants (n=19) did not own a smartphone and were loaned a device for the trial 
duration. Nonetheless, as the costs of mobile technology decrease, mobile technology 
interventions will be increasingly feasible and useful at all SES levels. 
47 
3.6.3 From Single-Arm Pilot to Randomized Controlled Trial 
  The pilot study was intended to generate results guiding the eventual design of a 
randomized controlled trial (RCT). Several points of guidance were readily apparent. First, the 
lower SES participants, according to our pilot experience, would not likely sustain participation 
if they perceived that randomization to the control group resulted in an inferior intervention. This 
was due to generic participation obstacles, especially taking time out of inflexible work 
schedules to attend assessment sessions. This observation combined with our interest in seeing 
what additional benefits were attributable to health coaching with the smartphone software vs 
health coaching alone. Accordingly, the health coaching intervention was designed to be 
fundamentally equivalent across comparison arms except for use of the smartphone plus software 
in the experimental group. Second, our experience with primary care providers involved their 
inconsistent provision of HbA1c tests. Accordingly, we ensured a point-of-care HbA1c Analyzer 
was available (via finger-prick A1c blood samples) throughout the current RCT.  
3.6.4 Limitations 
This pilot study enrolled a small convenience sample with no control group, limiting the 
generalizability of intervention results. Throughout the pilot trial, temporary software 
malfunctions and upgrades inevitably resulted in service disruptions. Although participants could 
directly log healthy behaviors via smartphone, their self-report could be falsified or exaggerated. 
Future studies can employ Bluetooth connected technology (ie, glucometers, accelerometers) to 
omit some self-report biases. To more rigorously assess intervention efficacy, the RCT now in 
the field is being undertaken with stabilized, consistently functional software. The goal is to 
assess whether health coaching without vs with the use of the smartphone software is equivalent 
(or non-inferior). In order to address this question, subjects were randomly allocated to 
experimental and control groups, and the same coaches delivered health coaching in both arms. 
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This approach aims to better understand which intervention features are most important to 
effective intervention. We understand that there are limitations to this assessment approach but it 
represents an important step in investigating these interventions. 
3.6.5 Comparison with Prior Work 
The most comparable intervention is the WellDoc diabetes trial [105,170,171] in which 
26 primary health practices were randomized to provide one of four possible health coach 
intervention options to their patients. Across participating practices, 163 patients were intervened 
with intensities ranging from usual care to use of smartphone-assisted health coaching. 
Investigators found significant decreases in HbA1c in the highest intensity group. In that trial, 
participants on Medicaid and Medicare and those without health insurance were excluded. Our 
trial specifically targets individuals from a lower-resource sector of a large Canadian city, most 
of whom would have been excluded from the WellDoc trial. Since the association between type 
2 diabetes and poverty has been well demonstrated [12,13,19], our interests focus on 
interventions that serve people of all SES and have demonstrated efficacy with subjects from 
lower SES. 
3.6.6 Conclusions 
As mobile technology becomes more accessible, electronically assisted health coaching 
may emerge as a viable and effective means of managing chronic conditions through improved 
health behaviors across all SES. To help understand what parts of the intervention were 
responsible for changes in behavior (health coaching, remote monitoring), the RCT currently 
being conducted will assess the effectiveness of health coaching in type 2 diabetic patients both 
with and without the use of smartphone technology at multiple sites with diverse populations. 
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4.1 RATIONALE FOR STUDY #2  
4.1.1 Objectives 
 To compare the effectiveness of improving the health profile of patients with poorly 
controlled T2DM with a health coaching protocol administered by health coaches with and 
without the use of a mobile (smartphone) app in a lower SES community. 
4.1.2 Hypotheses 
While both groups will experience improvements in HbA1c, anthropometric and 
psychometric outcomes, participants who receive health coaching with mobile (smartphone) 
connectivity will achieve significantly greater improvements in HbA1c of near 0.6% (7 
mmol/mol) compared with those who receive health coaching alone. Intervention participants 
will also achieve significantly greater reductions in weight as well as improved mood as 
measured by the Satisfaction with Life Scale, PANAS, HADS, and SF-12 (V2). 
4.2 ABSTRACT 
Background: Adoptions of health behaviors are crucial for maintaining good health after type 2 
diabetes mellitus (T2DM) diagnoses. However, adherence to glucoregulating behaviors like 
regular exercise and balanced diet can be challenging, especially for people living in lower-
socioeconomic status (SES) communities. Providing cost-effective interventions that improve 
self-management is important for improving quality of life and the sustainability of health care 
systems. 
Objective: To evaluate a health coach intervention with and without the use of mobile phones to 
support health behavior change in patients with type 2 diabetes. 
Methods: In this pragmatic randomized controlled trial (RCT), patients from two primary care 
health centers in Toronto, Canada, with type 2 diabetes and a glycated hemoglobin/hemoglobin 
A1c (HbA1c) level of ≥7.3% (56.3 mmol/mol) were randomized to receive 6 months of health 
coaching with or without mobile phone monitoring support. We hypothesized that both 
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approaches would result in significant HbA1c reductions, although health coaching with mobile 
phone monitoring would result in significantly larger effects. Participants were evaluated at 
baseline, 3 months, and 6 months. The primary outcome was the change in HbA1c from baseline 
to 6 months (difference between and within groups). Other outcomes included weight, waist 
circumference, body mass index (BMI), satisfaction with life, depression and anxiety (Hospital 
Anxiety and Depression Scale [HADS]), positive and negative affect (Positive and Negative 
Affect Schedule [PANAS]), and quality of life (Short Form 
Health Survey-12 [SF-12]). 
Results: A total of 138 patients were randomized and 7 were excluded for a substudy; of the 
remaining 131, 67 were allocated to the intervention group and 64 to the control group. Primary 
outcome data were available for 97 participants (74.0%). While both groups reduced their 
HbA1c levels, there were no significant between-group differences in change of HbA1c at 6 
months using intention-to-treat (last observation carried forward [LOCF]) (p=.48) or per-
protocol (p=.83) principles. However, the intervention group did achieve an accelerated HbA1c 
reduction, leading to a significant between-group difference at 3 months (p=.03). This difference 
was reduced at the 6-month follow-up as the control group continued to improve, achieving a 
reduction of 0.81% (8.9 mmol/mol) (p=.001) compared with a reduction of 0.84% (9.2 
mmol/mol)(p=.001) in the intervention group. Intervention group participants also had 
significant decreases in weight (p=.006) and waist circumference (p=.01) while controls 
did not. Both groups reported improvements in mood, satisfaction with life, and quality of life. 
Conclusions: Health coaching with and without access to mobile technology appeared to 
improve glucoregulation and mental health in a lower-SES, T2DM population. The accelerated 
improvement in the mobile phone group suggests the connectivity provided may more quickly 
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improve adoption and adherence to health behaviors within a clinical diabetes management 
program. Overall, health coaching in primary care appears to lead to significant benefits for 
patients from lower-SES communities with poorly controlled type 2 diabetes. 
Trial Registration: ClinicalTrials.gov NCT02036892; 
http://clinicaltrials.gov/ct2/show/NCT02036892 (Archived by WebCite at 
http://www.webcitation.org/6b3cJYJOD) 
 
 
4.3 INTRODUCTION 
4.3.1 Overview 
The type 2 diabetes mellitus (T2DM) epidemic is an increasing economic and personal 
health burden that could be cost-effectively addressed with health coach (HC) interventions, 
assisted by mobile phone technologies [172]. HC interventions target health behavior changes 
aligned with self-determined goals leading to improved physical and mental health outcomes 
[113]. Chronic medical conditions are targeted when health behaviors adopted by patients can 
significantly reduce risks of worsened disease and disease complications [173]. 
Amid promising reports of computer and mobile phone-assisted health interventions 
[174], a dearth of studies focus on which types of personal interactions combine most effectively 
with current technologies.  Prior to this randomized controlled trial (RCT), we codeveloped, with 
NexJ Systems Inc, mobile phone software for logging health data (eg, blood glucose, blood 
pressure, mood, energy, and pain) and related activities (eg, exercise, diet, and stress) using 
secure, cloud-based storage. The software permits innovative comonitoring of client behaviors 
(eg, photographing meals) and transmission of reminder messages encouraging activation and 
adherence. As the HC reviews participant activities in real-time experience, these immediately 
responsive communications can prevent relapse and/or assist relapse recovery, as demonstrated 
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in a pilot study [173]. 
 Internet-based interventions have demonstrated significant improvements in 
glucoregulation in T2DM patients, as exemplified in a cluster RCT undertaken by Quinn et al. 
[105] where 4 different intensity levels of Internet-based support were compared; significant 
between-group differences in reduced glycated hemoglobin/hemoglobin A1c (HbA1c) were 
found when the most intense intervention (p<.001) was compared to usual care. This 
intervention consisted mainly of automated messages prompted by patient entries (eg, self-
assessed blood glucose) and the patients studied were all health insured, after exclusion of the 
noninsured population that is often associated with lower socioeconomic status (SES), higher 
T2DM prevalence, and poorer glucose control [12,13]. In contrast, our intervention included a 
high proportion of lower-SES patients as all Ontario residents are able to access essential health 
services free of charge via the Ontario Health Insurance Program (OHIP). Our trial focused on 
supporting participants in surmounting the additional challenges confronted by lower-SES 
community residents, such as poor neighbourhood walkability [16] and elevated consumption of 
energy-dense/nutrient-poor foods [175].  Failure to surmount these challenges often leads to an 
increased longitudinal use of health care resources due to more reactive use combined with 
poorer health status [176]. A further contrast was that our study was based on assessing HC 
interactions, with and without mobile phone-based support.  
Another more recent trial compared a mobile phone-based, self-management system with 
and without telephone-based health coaching in improving HbA1c levels, with a usual care 
control group. Both intervention groups accessed a mobile phone-based self-management system 
that enabled users to track blood glucose, diet, physical activity, and personal goals. The most 
intensive intervention group received health coaching delivered by a diabetes specialist nurse for 
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the first 4 months of the 12-month trial, with a total of five 20-minute phone contacts. Results 
indicated no significant between-group or within-group HbA1c differences [110].  The intensity 
of this HC intervention—five 20-minute phone contacts—was considerably lower than the levels 
applied in this study.   
 The importance of lowering HbA1c and improving glucoregulation in T2DM patients 
cannot be overemphasized as HbA1c is a robust indicator of complication risks and a widely 
accepted tool for T2DM diagnosis [30]. Without proper management, patients with T2DM are at 
increased risk for debilitating complications, particularly stroke [89], neuropathy leading to 
amputation and blindness [31], and death [177]. HbA1c reductions have been associated with 
carbohydrate control [178], vigorous exercise [179], and medication adherence [180].  
 While the economic pressures of funding interventions motivate technological 
developments that can, in part or whole, replace personal counseling interventions, studies that 
compare different HC intensities combined with different technologies are necessary to 
determine optimal proportions. The usefulness of such studies is exemplified by Nundy et al. 
[11] who assessed a mobile phone-based, automated text messaging and counselling intervention 
with type 2 diabetes patients.  In a quasi-experimental, two-group, pre-/post-design, intervention 
participants appeared to be 8.8% less costly during the 6-month intervention, than during the 6 
months preceding intervention engagement. These participants also reduced their HbA1c by 
0.7% leading to other potential longitudinal cost savings not yet evaluated [11]. Because all were 
participants in the University of Chicago employee health plan, relevant health care costs were 
accessed and compared. Once again, our study differs in that our sample included unemployed 
individuals who would have been ineligible for the health plan which this previous study relied 
on. 
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4.3.2 Objective 
Based on data from a previous pilot trial, this pragmatic RCT tested the effectiveness of a 
mobile phone-based health coaching protocol, versus one without mobile phone support, in 
reducing the HbA1c of patients with T2DM from a lower-SES community. 
4.4 METHODS 
4.4.1 Overview 
This pragmatic RCT proceeded with a 1:1 allocation ratio. Participants were recruited 
from 2 primary health clinics in Toronto, Canada, between March 2012 and October 2013. The 
populations served were from a lower-income neighborhood (90% of participants) and a 
midlevel-SES community (10% of participants). Patients were eligible for participation if 
diagnosed with T2DM, if they had an HbA1c ≥ 7.3% (56.3 mmol/mol) measured within 1 month 
of consent, and if they were under 70 years of age. Following pragmatic trial guidelines, there 
were no additional exclusion criteria (eg, no exclusion of individuals with psychiatric diagnoses). 
All study protocols were approved by the Research Ethics Boards at York University, North 
York Family Health Team, and North York General Hospital. This RCT was registered with 
ClinicalTrials.gov (NCT02036892) and reported following CONSORT-EHEALTH statement 
guidelines [181]. 
Recruitment was undertaken through phone contacts with eligible individuals identified 
via clinic electronic medical records. Additional recruitment assistance was obtained from 
associated diabetes education programs, primary care physicians, and locally practicing 
endocrinologists. 
When participants agreed to an initial meeting to discuss the study, their HbA1c findings 
were verified, the study protocol was explained, and informed consent was obtained. Eligible 
patients then completed demographic and psychometric questionnaires and were randomized. 
Table 1 presents the baseline characteristics of the participants. 
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Table 3. Baseline characteristics (as per study protocol). 
Baseline characteristics Whole sample 
(n=97), mean (SD) 
or n (%)a 
Intervention group 
(n=48), mean (SD) or n 
(%)a 
Control croup 
(n=49), mean (SD) 
or n (%)a 
Age in years, mean (SD) 53.2 (11.3) 53.1 (10.9) 53.3 (11.9) 
Location, n (%)    
 Site #1: BCCHCb 90 (93) 46 (96) 44 (90) 
 Site #2: NYFHTc 7 (7) 2 (4) 5 (10) 
Gender, n (%)    
 Male 27 (28) 17 (35) 10 (20) 
 Female 70 (72) 31 (65) 39 (80) 
Ethnicity, n (%)    
 First Nations 1 (1) 0 (0) 1 (2) 
 Black: African 5 (5) 3 (6) 2 (4) 
 Black: Caribbean 39 (40) 19 (40) 20 (41) 
 Caucasian 26 (27) 12 (25) 14 (29) 
 Hispanic 9 (9) 4 (8) 5 (10) 
 South Asian 4 (4) 3 (6) 1 (2) 
 South East Asian 4 (4) 2 (4) 2 (4) 
 West Indian 6 (6) 3 (6) 3 (6) 
 Other 3 (3) 2 (4) 1 (2) 
Highest education level 
achieved, n (%) 
   
 Less than high 
school 
22 (23) 10 (21) 12 (24) 
 High school diploma 35 (36) 17 (35) 18 (37) 
 College or 
vocational training 
25 (26) 11 (23) 14 (29) 
 University degree 12 (12) 8 (17) 4 (8) 
 Not disclosed 3 (3) 2 (4) 1 (2) 
Employment, n (%)    
 Unemployed 35 (36) 16 (33) 19 (39) 
 Student 4 (4) 3 (6) 1 (2) 
 Part time 6 (6) 1 (2) 5 (10) 
 Full time 25 (26) 13 (27) 12 (25) 
 Retired 11 (11) 6 (13) 5 (10) 
 Self-employed 9 (9) 6 (13) 3 (6) 
 Work in home (eg, 
take care of 
children) 
4 (4) 2 (4) 2 (4) 
 Not disclosed 3 (3) 1 (2) 2 (4) 
Income in Can $, n (%)    
 $0-$9999 21 (22) 9 (19) 12 (25) 
 $10,000-$25,000 23 (24) 10 (21) 13 (27) 
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 $25,000-$50,000 20 (21) 12 (25) 8 (16) 
 $50,000-$75,000 9 (9) 3 (6) 6 (12) 
 $75,000 and higher 5 (5) 4 (8) 1 (2) 
 Not disclosed 19 (20) 10 (21) 2 (4) 
Car access, n (%)    
 Owns a car 35 (36) 19 (40) 16 (33) 
 Has access to car 12 (12) 9 (19) 3 (6) 
 No access to car 48 (50) 19 (40) 29 (59) 
 Not disclosed 2 (2) 1 (2) 1 (2) 
 
aPercentages may not add up to 100% due to rounding. 
bBlack Creek Community Health Centre (BCCHC). 
cNorth York Family Health Team (NYFHT). 
4.4.2 Intervention 
The HC intervention extended for 6 months from the date of consent (Figure 12) 
following a behavior-change curriculum designed by 2 study authors (PR and NW) at York 
University that incorporated feedback from the prior pilot study [173]. In the intervention, a 
health coach was defined as a behavior-change counselling specialist with expertise in chronic 
disease management and evidence-based theory adapted for disease state, SES, and ethnocultural 
backgrounds. With HC assistance, clients determined health-related goals and monitored daily 
progress. The HC comonitored the client’s mobile phone input and directed immediate attention 
(on a 24-hour/day and 7-day/week basis) to episodes of desirable progress, relapse, and 
resistance. The HC protocol has been manualized, emphasizing those situations observed to 
frequently arise when behavior change is addressed in T2DM-affected individuals. 
Eligible participants were randomized to the respective study groups (with and without 
mobile phone support), with HCs in both groups guiding participants in planning and reaching 
health targets aimed at reducing HbA1c. Efforts focused primarily on increasing exercise 
(frequency, duration, intensity) and modifying diet to reduce carbohydrate intake. Additional 
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goals emphasized stress management, medication adherence, and effective communication with 
primary care physicians and, generally, within the health system. 
Six HCs intervened with experimental and control group participants. These individuals 
held bachelor’s degrees in kinesiology and health science and/or were graduate students in the 
School of Kinesiology and Health Science at York University. Five HCs were certified exercise 
physiologists—certified by the Canadian Society for Exercise Physiology (CSEP)—and one was 
a certified personal trainer—certified by the CSEP. All attended weekly seminars prior to and 
throughout the trial where they received training in the HC curriculum by the lead investigator 
(PR). HCs also participated in weekly team meetings led by the study coordinator (NW) where 
they discussed applications of behavior theory in specific strategies for each participant. 
The Black Creek Community Health Centre (BCCHC) concurrently provided the 
Exercise Education Program (EEP) to all community members (free of charge) that featured 
exercise prescription, monitoring, and adherence support. Participants were monitored on both an 
individual and group basis by trainers during exercise sessions and patients with T2DM were 
provided with special blood glucose testing before and after each exercise session. The program 
included group exercise classes, resistance training with weights and bands, and cardiovascular 
exercise using a treadmill and stationary bicycles. Both intervention and control group 
participants had EEP access for the trial duration. 
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Figure 12 - Experimental design & timing of data collection. 
 
4.4.3 Intervention Group 
The intervention group was provided with a Samsung Galaxy Ace II mobile phone 
running Google Android Ice Cream Sandwich (Android 4.0.2) for the study intervention period, 
with a data-only carrier plan. They were also provided a user account with the Connected 
Wellness Platform (CWP) provided by NexJ Systems, Inc., which supported participants in 
health-related goal setting and progress monitoring. Participants could track key metrics, notably 
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blood glucose levels (Figure 13), exercise frequency/duration/intensity (Figure 14), food intake 
(via photo journaling) (Figure 15), and mood (Figure 16). They could communicate with their 
health coach at any time in the 24-hour cycle via secure messaging, scheduled phone contact, 
and/or during in-person meetings. The mean total contact (for all these activities) was 38 
minutes/week (SD 25). All health data entered by participants into the CWP were immediately 
visible to health coaches through a secure, Web-accessible portal. Although participants were 
encouraged to use the system daily, individual usage patterns varied. Participant data and 
software-enabled communication required two-way, certificate-based authentication and 
passwords that were stored in encrypted columns. The CWP exceeds Canadian privacy standards 
for software carrying health information. Based on patient goals, HCs used the 24-hour/day 
logging function to guide healthy lifestyle choices, while providing support when clients 
diverged from intended health goals and routines. 
Figure 13 - Screenshot of blood glucose tracker. 
 
Figure 14 - Screenshot of exercise tracker. 
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Figure 15 - Screenshot of food tracker. 
 
Figure 16 - Screenshot of mood tracker. 
 
 
4.4.4 Control Group 
Control group participants received HC support in selecting and progressing toward goals 
without access to a (study-provided) mobile phone or the CWP software. Control group 
participants accessed the EEP, as did the intervention group participants for the study duration, in 
addition to in-person meetings and health coach phone contacts. 
4.4.5 Primary Outcomes 
The primary outcome was the difference between intervention and control group means of 
HbA1c levels from baseline to 6 months. Intention-to-treat and per-protocol analyses were both 
undertaken and are presented below. HbA1c levels were assessed by physician requisition or, 
when unobtainable, by a point-of-care HbA1c analyzer (Siemens DCA Vantage 3000) which has 
met performance criteria in efficacy trials [182] and has been employed in comparable research 
[110,183]. To ensure consistency, the type of HbA1c collection at baseline was the same at 
follow-up sessions. While the 3-month assessment allowed an evaluation of trends, the 6-month 
assessment was used to calculate the primary outcome. Measures of blood work were accepted 
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within 4 weeks of the 3- and 6-month measurement intervals providing flexibility for participant 
schedules and physician requisitions. 
4.4.6 Secondary Outcomes 
Differences between HbA1c mean levels within groups were also analyzed. Additional 
outcomes included anthropometric measurements for weight (kg), body mass index (BMI) 
(kg/m2), and waist circumference (cm) collected at baseline and six-month time points. Changes 
in psychometric assessments at baseline and 6-months were analyzed using the Satisfaction with 
Life Scale [140], the Hospital Anxiety and Depression Scale [141], the Positive and Negative 
Affect Schedule [143], and the Short Form Health Survey-12 (SF-12) [144]. All measures were 
obtained on site by research staff. 
4.4.7 Sample Size 
An a priori power calculation indicated 48 participants were needed per group to detect 
an estimated difference of HbA1c of 0.65%, assuming a significance level of 5% (two-tailed), 
standard deviation of 1.4 and a statistical power of 80%. We over-enrolled to allow for attrition, 
setting our final recruitment target at 65 participants per group.  
4.4.8 Randomization 
A random number sequence was generated using a random number-generating program 
without constraints (www.randomizer.org). After the sequence was generated by the research 
coordinator, a research assistant with no connection to the trial sealed the sequence in individual, 
opaque envelopes and numbered each based on sequence generation. Once a candidate 
participant consented and their HbA1c was verified as meeting the inclusion criteria, the next 
envelope was opened (in sequence) to ascertain group allocation, and the health coaching 
intervention commenced. Patient and coach blinding was impossible as participants readily 
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identified receipt of a mobile phone with experimental group participation and the absence of 
receipt with control group participation. 
4.4.9 Statistical Analysis 
Data were double entered by 2 independent research assistants to ensure accuracy. Baseline 
characteristics between intervention and control groups were compared for differences using 
independent samples t tests for continuous variables and chi-square for dichotomous variables. 
Primary outcome comparison was conducted with an independent samples t test using per-
protocol (only those who completed the trial) and intention-to-treat analyses (last observation 
carried forward [LOCF]). Secondary outcome comparisons were conducted solely using per-
protocol comparisons with a factorial repeated-measures analysis of variance (ANOVA) 
(randomization group as factor). Data were analyzed using SPSS 21.0 (IBM Corp, Armonk, NY, 
USA). 
4.5 RESULTS 
4.5.1 Overview 
Between March 2012 and October 2013, 138 participants were recruited; 67 were 
randomized to the experimental arm and 64 to the control arm (7 were excluded for substudy 
analysis) as seen in the CONSORT diagram (Figure 6). A majority of participants (57/97, 59%) 
had not completed postsecondary education and 35 out of 97 (36%) were unemployed, while a 
total of 64 out of 97 (66%) reported household incomes of Can $50,000 or less. A majority of 
participants were recruited from Site Number 1 (90/97, 93%) and were female (70/97, 72%). Of 
the 131 participants included in the study, there were 34 dropouts (26%), with 19 out of 67 
(28%) from the intervention group and 15 out of 64 (23%) from the control group. Independent 
samples t tests indicated no statistically significant differences between dropouts and trial 
completers for HbA1c or for demographic variables. Final per-protocol analysis included 97 
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participants out of 131 (74%), with 48 in the intervention group and 49 in the control group. Of 
the measures collected, differences at baseline between groups were only detected for the SF-12 
Mental Health Composite Scores. Of the 48 participants allocated to the mobile phone group, 
mobile phone use data indicated that 39 out of 48 participants (81%) used the CWP with 
consistency (at least once per week through the trial) to communicate with their health coach and 
track various health measures (eg, blood glucose, food, and/or exercise). 
Figure 17 - Flow Chart of enrolment and patient status (n=131) 
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4.5.2 Hemoglobin A1c 
Independent samples t tests indicated no significant between-group differences in HbA1c 
from baseline to 6 months when analyzed with intention-to-treat (p=.48) and per-protocol 
(p=.83) principles (Table 4). 
Table 4 – Independent samples t test measuring differences in HbA1c levels from baseline to 6 months 
 N Intervention 
mean (SD) 
Control mean 
(SD) 
Difference  P (two-tailed) 
HbA1c:  Per Protocol 97 -0.815 (1.050) -0.759 (1.390) 0.055 .83 
HbA1c: Intention to Treat 131 -0.642 (1.040) -0.974 (1.400) 0.152 .48 
Results from a repeated-measures ANOVA indicated trends for between-group HbA1c 
differences in a per-protocol analysis—F1,89=3.022, p=.09 (Table 5). 
 
Table 5 Between-group analysis of variance measuring differences in HbA1c levels. 
 N Type II Sum 
of Squares 
Df Mean 
Square 
F  Sig.  Partial Eta 
Squared 
HbA1c – Per Protocol 97 3.004 1 3.004 3.002 .086 .034 
HbA1c – Intention to Treat 131 1.463 1 1.463 1.142 .287 .009 
 
 
These differences reflected significant HbA1c within-group reductions from baseline to 6 
months in the intervention group—0.84% (9.2 mmol/mol), 95% CI [0.46-1.17]; p=.001—and in 
the control group—0.81% (8.9 mmol/mol), 95% CI [0.41-1.11]; p=.001—(Table 4), and a 
significantly greater reduction for the intervention group versus the control group at the 3-month 
follow-up (p=.03; Table 6). 
Table 6. Change in HbA1c levels by group. 
Measurement time point Intervention group Control group 
  n Mean % (SD or 
95% CI) 
Total value 
(mmol/mol) 
n Mean % (SD or 
95% CI) 
Total value 
(mmol/mol) 
 
HbA1c included in t test (n=97)       
 Baseline, mean (SD) 48 8.69 (1.32) 71.5  49 8.89 (1.30) 73.7  
 6 months, mean (SD) 48 7.88 (1.17) 62.6  49 8.13 (1.27) 65.4  
 Change from baseline to 6 
months, mean (95% CI) 
48 0.82 (0.46-1.17)a 8.9  49 0.76 (0.41-1.11)a 8.3  
HbA1c included in ANOVAb 
(n=89) 
      
 Baseline, mean (SD) 45 8.60 (1.19) 70.5  44 8.88 (1.32) 73.6  
 3 months, mean (SD) 45 7.74 (1.06) 61.1  44 8.26 (1.16) 66.8  
 6 months, mean (SD) 45 7.76 (1.00) 61.3  44 8.07 (1.29) 64.7  
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 Change from baseline to 3 
months, mean (95% CI) 
45 0.86 (0.47-1.26)a 9.4  44 0.62 (0.23-1.03)a 6.8  
 Change from baseline to 6 
months, mean (95% CI) 
45 0.84 (0.38-1.26)a 9.2  44 0.81 (0.34-1.28)a 8.9  
aSignificant at the p=.001 level 
bAnalysis of variance (ANOVA). 
 
A data discrepancy was detected during the repeated-measures ANOVA as 3 participants 
in the intervention group and 5 in the control group were not assessed at 3 months but were 
evaluated at 6 months. They had either refused the 3-month testing or their family physicians 
failed to provide their test results. Subsequent t tests indicated a lesser reduction in HbA1c 
(baseline to 6 months) for the controls lacking the 3-month data versus completers (p=.03). 
There were no differences in HbA1c (baseline to 6 months) for intervention participants lacking 
3-month data versus those with complete data. Furthermore, no significant differences were 
found in baseline HbA1c levels for either intervention or controls participants with or without a 
3-month HbA1c measure. 
Table 7. HbA1c values for participants with and without 3-month measurements. 
Measurement Intervention group Control group 
 3-month measure 
absent (n=3) 
3-month measure 
present (n=45) 
P 3-month measure 
absent (n=5) 
3-month measure 
present (n=44) 
P 
 
Baseline HbA1c, 
mean % (SD) 
9.97 (2.64) 8.60 (1.19) .47 8.92 (1.19) 8.88 (1.33) .95 
Total HbA1c value 
(mmol/mol) 
85.5 70.5  74 73.6  
Change in HbA1c  
(6 month-baseline), 
mean % (SD) 
-0.40 (0.46) -0.84 (1.08) .47 -0.28 (0.19) -0.81 (1.45) .03 
 
Table 8 presents that the HbA1c trend differences indicated with the repeated-measures 
ANOVA—F1,89=3.022, p=.09—were due to the greater reduction of HbA1c at 3 months in the 
intervention versus control group.  This between-group difference disappeared at 6 months with 
gains in the control group, and no further gains in the intervention group.  
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Table 8. Time-point comparison of HbA1c levels for intervention versus control groups. 
Time point Between-group difference of % HbA1c (95% CI) P 
Baseline 0.280 (-0.250 to 0.810) .30 
3 months 0.515 (0.500 to 0.990) .03 
6 months 0.308 (-0.180 to 0.800) .21 
 
 When the factorial repeated measures ANOVA was rerun controlling for participation in 
the EEP as a possible confounding variable, the model suggested change in HbA1c was 
independent of use of the onsite exercise program F1,82=2.264, p=.136. 
Table 9: Between-Group Effects on HbA1c controlling for the Exercise Education Program (Per Protocol) 
 Type III Sum 
of Squares 
df Mean Square F Sig. Partial Eta 
Squared 
EER Participation 3.663 1 3.663 1.201 .276 .014 
Group 6.907 1 6.907 2.264 .136 .027 
 
 
 
 
Figure 18 – Mean HbA1c Levels Over Time 
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4.5.3 Secondary Outcomes: Body Composition (Per protocol) 
We detected significant reductions in body weight (1.22 kg, 95% CI [0.35, 2.08]; p=.006) 
and waist circumference (2.23 cm, 95% CI [0.53, 3.93]; p=.01) in the intervention group, while 
the control group had no change. There were no significant changes in BMI in either group (10). 
4.5.4 Secondary Outcomes: Psychometric Questionnaires (Per protocol) 
A significant number of trial completers chose not to complete psychometric 
questionnaires at follow-up, resulting in their baseline outcomes being omitted from additional 
analyses (Table 10). Comparison of the baseline psychometric outcomes of completers and 
noncompleters indicated no significant differences. 
Within-group, pre/post improvements in life satisfaction were detected in the intervention 
(+3.72, 95% CI [1.50, 5.94]; p=.001) and control groups (+3.77, 95% CI [1.30, 6.24]; p=.003) 
(Satisfaction with Life Scale). Similar improvements for both intervention and control groups 
were detected in the Hospital Anxiety and Depression Scale (HADS) depression subscale (-1.81, 
95% CI [-2.81, -0.81]; p=.001; -1.70, 95% CI [-2.73, -0.67]; p=.002), and the Physical 
Composite Score of the SF-12 (+2.69, 95% CI [0.21, 5.17]; p=.03; +2.92, 95% CI [0.24, 5.60]; 
p=.03) (Table 10), although the control group demonstrated a significantly reduced HADS 
anxiety subscale score (-1.50, 95% CI [-2.73, -0.27]; p=.02), while the intervention group did not 
(-1.12, 95% CI [-2.29, 0.05]; p=.06) (Table 10). Significant between-group differences were 
found at the 6-month follow-up for negative affect (negative affect subscale of the Positive and 
Negative Affect Schedule [PANAS]) (+5.27, 95% CI [1.51, 9.04]; p=.007) favoring the 
intervention group (Table 10). 
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Table 10. Baseline, follow-up, and change values for all secondary outcomes.  
Variable by group n Baseline, mean (SD 
or 95% CI) 
6-month follow-up, 
mean (SD or 95% CI) 
Change,  
mean (95% CI) 
P 
Weight (kg)      
 Intervention 41 93.66 (20.23) 92.44 (20.24) -1.22 (0.35-2.08)a .006 
 Control 39 98.76 (24.02) 99.21 (24.77) +0.45 (-1.33 to 0.44) .32 
 Difference between 
groups 
 5.10 (-4.78 to 14.98) 6.76 (-3.29 to 16.81)   
 P  .31 .18   
Waist circumference (cm)      
 Intervention 40 112.11 (14.50) 109.88 (14.82) -2.23 (0.53-3.93)a .01 
 Control 37 113.88 (17.04) 114.00 (18.12) +0.122 (-1.89 to 1.64) .89 
 Difference between 
groups 
 1.78 (-5.39 to 8.94) 4.13 (-3.36 to 11.62)   
 P  .62 .28   
Body mass index (kg/m2)      
 Intervention 39 33.74 (6.70) 33.53 (6.80) -0.21 (-0.24 to 0.66) .35 
 Control 36 37.00 (7.92) 37.21 (8.22) -0.21 (-0.68 to 0.25) .37 
 Difference between 
groups 
 3.26 (-0.11 to 6.63) 3.69 (0.22-7.15)a   
 P  .06 .04   
Satisfaction with Life      
 Intervention 32 20.50 (7.71) 24.22 (6.33) +3.72 (1.50-5.94)b .001 
 Control 26 18.04 (7.01) 21.81 (7.15) +3.77 (1.30-6.24)b .003 
 Difference between 
groups 
 -2.46 (-1.46 to 6.38) -2.41 (-1.14 to 5.96)   
 P  .21 .18   
HADSc: anxiety subscale      
 Intervention 33 7.39 (4.53) 6.27 (4.18) -1.12 (-2.29 to 0.05) .06 
 Control 30 9.50 (4.49) 8.00 (5.06) -1.50 (-2.73 to -0.27)a .02 
 Difference between 
groups 
 2.11 (-0.17 to 4.39) 1.73 (-0.60 to 4.06)   
 P  .07 .14   
HADS: depression 
subscale 
     
 Intervention 32 6.25 (3.99) 4.44 (3.32) -1.81 (-2.81 to -0.82)b .001 
 Control 30 7.77 (4.06) 6.07 (4.38) -1.70 (-2.73 to -0.67)b .002 
 Difference between 
groups 
 1.52 (-0.53 to 3.56) 1.63 (-0.34 to 3.60)   
 P  .14 .10   
PANASd: positive affect 
subscale 
     
 Intervention 30 34.43 (8.46) 36.03 (7.65) +1.60 (-1.00 to 4.20) .22 
 Control 27 31.22 (10.29) 31.67 (9.71) +0.44 (-2.30 to 3.18) .75 
 Difference between 
groups 
 -3.21 (-1.77 to 8.19) -4.37 (-0.25 to 8.98)   
 P  .20 .06   
PANAS: negative affect 
subscale 
     
 Intervention 31 16.58 (7.85) 14.55 (5.03) -2.03 (-4.87 to 0.80) .16 
 Control 28 20.39 (9.57) 19.82 (9.04) -0.57 (-3.55 to 2.41) .70 
 Difference between 
groups 
 3.81 (-0.73 to 8.36) 5.27 (1.51-9.04)a   
 P  .10 .007   
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SF-12e: Physical 
Composite Score 
     
 Intervention 34 42.89 (8.69) 45.57 (7.54) +2.69 (0.21-5.17)a .03 
 Control 29 41.63 (10.08) 44.55 (10.89) +2.92 (0.24-5.60)a .03 
 Difference between 
groups 
 1.25 (-3.48 to 5.98) 1.02 (-3.65 to 5.68)   
 P  .60 .66   
SF-12: Mental Composite 
Score 
     
 Intervention 34 47.74 (11.11) 50.22 (10.29) +2.48 (-1.10 to 6.05) .17 
 Control 29 41.68 (11.82) 44.50 (10.15) +2.82 (-1.05 to 6.69) .15 
 Difference between 
groups 
 6.06 (0.28-11.85)a 5.72 (0.56-10.89)a   
 P  .04 .03   
aThe change is significant, p<.05. 
bThe change is significant, p<.005. 
cHospital Anxiety and Depression Scale (HADS). 
dPositive and Negative Affect Schedule (PANAS). 
e12-Item Short Form Health Survey (SF-12). 
 
4.5.5 Secondary Outcomes: Body Composition (Intention to Treat) 
We detected significant reductions in body weight (0.798 kg, 95% CI [0.35, 2.08]; 
p=.006) and waist circumference (1.69 cm, 95% CI [0.55, 2.83]; p=.004) in the intervention 
group, while the control group had no change. There were no significant changes in BMI in 
either group (10). 
4.5.6 Secondary Outcomes: Psychometric Questionnaires (Intention to Treat) 
Within-group, pre/post improvements in life satisfaction were detected in the intervention 
(+2.16, 95% CI [0.84, 3.49]; p=.002) and control groups (+1.44, 95% CI [0.16, 2.72]; p=.028) 
(Satisfaction with Life Scale). Similar improvements for both intervention and control groups 
were detected in the Hospital Anxiety and Depression Scale (HADS) depression subscale (-1.04, 
95% CI [0.42, 1.65]; p=.001; -0.79, 95% CI [0.18, 1.40]; p=.012), and the Physical Composite 
Score of the SF-12 (+1.63, 95% CI [0.17, 3.09]; p=.029; +1.46, 95% CI [0.3, 2.90]; p=.046) 
(Table 11), although the control group demonstrated a significantly reduced HADS anxiety 
subscale score (-0.71, 95% CI [0.02, 1.39]; p=.044), while the intervention group did not (0.69, 
95% CI [-0.03, 1.40]; p=.059) (Table 11). 
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Table 11. Baseline, follow-up, and change values for all secondary outcomes (ITT) 
Variable by group n Baseline, mean (SD 
or 95% CI) 
6-month follow-up, 
mean (SD or 95% CI) 
Change,  
mean (95% CI) 
P 
Weight (kg)      
 Intervention 63 91.64 (19.14) 90.84 (19.05) -0.798 (.235 to 1.361)a .006 
 Control 63 95.80 (23.63) 96.11 (24.04) +.312 (-.875 to 0.251) .275 
 Difference between 
groups 
 4.16 (-11.741 to 
3.43) 
5.27 (-12.92 to 2.38)   
 P  .28 .18   
Waist circumference (cm)      
 Intervention 61 110.96 (15.02) 109.27 (15.45) -1.69 (.55 to 2.83)b .004 
 Control 62 112.17 (16.61) 112.40 (17.06) +.23 (-1.36 to 0.91) .694 
 Difference between 
groups 
 1.21 (-6.86 to 4.45) 3.12 (-8.94 to 2.69)   
 P  .674 .290   
Body mass index (kg/m2)      
 Intervention 58 33.56 (6.55) 33.41 (6.61) -0.14 (-.15 to 0.44) .336 
 Control 61 35.91 (8.02) 36.07 (8.18) +0.16 (-.44 to 1.26) .271 
 Difference between 
groups 
 2.36 (5.02 to 0.31) 2.66 (5.37 to 0.05)   
 P  .083 .054   
Satisfaction with Life      
 Intervention 55 19.58 (7.96) 21.74 (7.72) +2.16 ( 0.84 to 3.49)b .002 
 Control 59 19.17 (7.00) 20.61 (7.19) +1.44 (0.16 to 2.72)a .028 
 Difference between 
groups 
 .412 (-2.36 to 3.19) 1.14 (-1.63 to 3.90)   
 P  .769 .418   
HADSc: anxiety subscale      
 Intervention 54 7.50 (4.56) 6.81 (4.40) +0.69 (-0.03 to 1.40) .059 
 Control 58 8.95 (4.52) 8.24 (4.73) -0.71 (0.02 to 1.39) .044 
 Difference between 
groups 
 1.45 (-3.13 to 0.23) 1.43 (-3.14 to 0.29)   
 P  .091 .102   
HADS: depression 
subscale 
     
 Intervention  6.11 ( 3.98) 5.07 (3.68) -1.04 (0.42 to 1.65)b .001 
 Control  7.18 (4.12) 6.39 (3.68) -0.79 (0.18 to 1.40)a .012 
 Difference between 
groups 
 1.07 (-2.58 to 0.44) 1.32 (-2.80 to .17)   
 P  .164 .082   
PANASd: positive affect 
subscale 
     
 Intervention 55 33.76 (8.39) 34.64 (8.07) +0.87 (-2.30 to .55) .227 
 Control 55 32.40 (9.19) 32.69 (8.84) +0.29 (-1.71 to 1.13) .686 
 Difference between 
groups 
 1.36 (-7.96 to 4.69) 1.95 (-1.25 to 5.15)   
 P  .418 .231   
PANAS: negative affect 
subscale 
     
 Intervention 55 17.13 (7.23) 15.98 (5.86) -1.15 (-.44 to 2.73) .154 
 Control 56 20.20 (9.89) 20.18 (9.60) -0.2 (-1.55 to 1.55) .982 
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 Difference between 
groups 
 3.07 (-6.33 to .194) 4.20 (-7.20 to -1.2)   
 P  .065 .007a   
SF-12e: Physical 
Composite Score 
     
 Intervention 56 41.37 (9.54) 43.00 (9.31) +1.63 (0.17 to 3.09)a .029 
 Control 58 40.90 (10.13) 42.36 (10.74) +1.46 (0.3 to 2.90)a .046 
 Difference between 
groups 
 0.47 (-3.19 to 4.12) 0.64 (-3.10 to 4.37)   
 P  .801 .73   
SF-12: Mental Composite 
Score 
     
 Intervention 56 47.91 (10.02) 49.42 (9.52) +1.50 (-3.57 to 0.56) .152 
 Control 58 44.10 (11.23) 45.51 (10.15) +1.41 (-3.44 to 0.62) .171 
 Difference between 
groups 
 3.81 (-0.14 to 7.77) 3.91 (0.25 to 7.56)   
 P  .059 .036   
aThe change is significant, p<.05. 
bThe change is significant, p<.005. 
cHospital Anxiety and Depression Scale (HADS). 
dPositive and Negative Affect Schedule (PANAS). 
e12-Item Short Form Health Survey (SF-12). 
 
 
4.6 DISCUSSION 
4.6.1 Principal Findings 
Personalized health coaching with and without the provisions of mobile phone and 
related software support was assessed in a predominantly lower-SES population with poorly 
controlled T2DM. A total of 45% of participants reported household incomes of Can $25,000 or 
less, qualifying them as living at or beneath the Canada poverty line [184] while an additional 
20.9% of participants reported household incomes between Can $25,000 and Can $50,000. Our 
findings suggest clinically significant within-group reductions in HbA1c in both groups but no 
significant between-group differences in HbA1c from baseline to 6 months according to per-
protocol (p=.83) and intention-to-treat (LOCF) (p=.48) analyses. 
There was a significant between-group difference in HbA1c at the 3-month time point 
(0.52%, p=.03) favouring the mobile phone-assisted group. However, this difference lost 
significance at 6 months as the control group’s mean HbA1c reduction continued to improve 
while the intervention group’s HbA1c level remained stable between 3 and 6 months (Figure 18). 
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This result indicates that clinically significant HbA1c reductions occurred at a faster rate with 
HC and mobile phone support than with solely HC support. The repeated-measures ANOVA 
analysis of three time points was affected by missing data; however, all missing control 
participants had no HbA1c reductions, resulting in an increased mean difference in remaining 
controls necessitating a larger effect size in the experimental condition to reflect a significant 
difference. 
The purpose of increasing the frequency and intensity of any health behavior in T2DM 
patients is improved glucoregulation, which directly and/or indirectly influences health-related 
quality of life (HRQOL). It is important to assess HRQOL outcomes independently through 
secondary RCT analyses, as improvements in physical health not associated with positive 
changes in quality of life are not likely sustainable. 
Observed weight and waist circumference differences also suggested comparative 
benefits for the mobile phone-assisted group versus controls. These included significant 
reductions in weight and waist circumference in the mobile phone group, which may be related 
to the food photo-journaling function of the CWP. By reviewing photographs of their meals, 
participants could reflect on portion size and nutritional value in discussion with the health 
coach. These photo-stimulated "teachable moments" appeared to improve dietary choices more 
than was evident in the health coach-only group. Those in the mobile phone group also 
subjectively reported value in photographing meals and recording glucose levels in response to 
in-depth semistructured interviews [185]. Reductions in negative affect are likely linked to 
intervention participants feeling fundamentally connected in their health-focused program as 
their mobile phone became a constant symbol of being able to access a genuinely concerned 
person (24 hours a day/7 days a week) whose sole purpose was to help address health concerns. 
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This feeling of health coach connectedness was a principal theme in the qualitative analyses of 
participant interviews [185]. 
Lower-SES populations confront higher mortality risks than equivalent higher-SES 
populations [12]. Due to a variety of challenges to health maintenance, individuals from lower-
SES communities have poorer health status and use health care services more reactively [176]. 
They are also more likely to suffer from mental health conditions [186], but less likely to access 
mental health resources [187]. Our results indicate that psychological well-being within the 
overall sample improved from baseline to 6-month follow-up, specifically demonstrated in 
outcomes on the Satisfaction with Life and the Hospital Anxiety and Depression Scales. It is our 
conjecture that frequent (minimum once per week) communication with their HC was related to 
the improvements in self-reported mood. Although differences in our primary outcome (HbA1c 
level) were only trending toward significant between-group differences, significant differences 
appeared in other markers of basic health (ie, weight and waist circumference), and in the 
negative affect subscale of the PANAS. Once again, those who used the mobile phone 
subjectively reported value in photographing meals and recording blood glucose levels when 
responding to in-depth semistructured interviews [185]. 
The Connected Wellness Platform enabled self-monitoring and health coach interactions 
with intervention participants, providing a cloud-based platform for mobile phone-based health 
management. This system provided secure, two-way communication between client and health 
coach, with mobile phone data entry on relevant behaviors entered manually. While the 
restriction to manual entry was not ideal, Bluetooth functionality for glucometers and 
pedometers was not yet integrated into the system during the trial. Other chronic disease 
management systems with similar features have been tested for usability and functionality. 
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Notably, Martinez-Millana et al. [188] comprehensively tested a diabetes management system 
with 30 patients and assessed the speed accuracy of tracking with several Bluetooth-enabled 
devices (ie, glucometers and pedometers) and their performance with a variety of mobile phones 
and network connections. Although we did not focus on the same performance analysis criteria 
during this trial, the CWP went through multiple upgrades during the pilot trial [173], ensuring 
smoother functionality and a more refined user interface (Figures 13-16) for the RCT. Detailed 
user experience with the CWP was collected using semistructured interviews and is reported in a 
full-length article [185]. CWP-user data logs were also extracted and analyzed with data mining 
methods to evaluate more finely tuned associations between app use and clinical outcomes (in a 
submitted manuscript). 
Careful titrations of health coach interventions, typically measured by the frequency and 
duration of patient-coach interactions, are important elements in determining the optimal HC 
contact for eliciting improved health at minimal cost. With too little interaction, HC 
interventions risk insignificant or unsustainable health improvements, while too much interaction 
results in overly expensive implementation. As such, studies using multiple intervention 
intensities are necessary to ultimately determine appropriate contact level. Although we did not 
specify a minimum-maximum intervention intensity during the trial (providing weekly contact 
was maintained), the mean interaction intensity was 38 min/week (SD 25). In both intervention 
and control conditions, significant improvements in HbA1c levels and psychological functioning 
were found. The mobile technology appeared useful in engaging participants more quickly such 
that significantly greater HbA1c reductions were evident at 3 months (compared to controls), 
which may have cost-effectiveness implications as these gains were stabilized and evident at 6 
months, although additional improvements in controls ultimately erased the 3-month differences.  
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While the gains made at 3 months were sustained at 6 months (in the intervention group), there is 
no evidence that gains made in either group were sustained beyond the 6-month follow-up. 
In contrast to our relatively high intensity human interaction intervention, Nundy et al. 
[11] used a mostly automated messaging system that followed a standardized curriculum 
delivered to participants electronically, while a registered nurse monitored their progress and 
only made outbound calls to patients in exceptional circumstances, specifically when the patient 
activated an ‘alert’. While investigators were successful improving gluco-regulation in their 
intervention group by 0.7% (HbA1c) compared to control, this was a quasi-experimental, non-
randomized design, where participants chose which group they participated in, leading to 
selection bias. This trial did succeed in estimating potential cost savings of $437USD for 
intervention participants [11]. Blackberry et al. [95] tested a less intensive telephonic health 
coach intervention provided by general practitioner nurses delivering a median of four coaching 
sessions/participant over 18 months, averaging 30 min/session and focused primarily on 
increasing medication adherence, lifestyle modification and symptom monitoring. Results 
indicated no differences between or within intervention and usual care control groups in HbA1c. 
Similarly, Holmen et al. [189] also found no differences in HbA1c between groups and only 
modest reductions within groups ranging from 0.31%, 95% CI [–0.67, 0.05] for the app only 
group, 0.16%, 95% CI [-.58, 0.29] for app with health coaching, and 0.15%, 95% CI [-0.5, 0.18] 
for control participants, also suggesting more intensive health coaching interventions are needed 
when accompanying remote monitoring technology. 
A unique feature of our study was the enhanced usual care that at least partly explains 
gains achieved by both control and intervention participants. The BCCHC site maintained a 
clinical exercise program that was several yards from the primary care physician and diabetes 
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education team offices, symbolizing the importance of exercise in health maintenance, while 
serving patients in need. Moreover, the program provided T2DM patients with education, 
exercise prescription, and monitoring, which included the assessment of blood glucose levels 
before and after every supervised exercise session. This supported patients in recognizing the 
benefits of exercise in blood glucose regulation, and helped encourage adoption of home-based 
exercise programs. Since the HCs in this trial were all certified exercise specialists (through the 
Canadian Society for Exercise Physiology), exercise prescription was undertaken safely, with no 
adverse events, according to the highest evidence-based standards. A total of 23 intervention 
patients and 22 control patients participated in the Exercise Education Program.  Although we 
might have included a control condition that did not access the EEP, the EEP was adopted as 
usual care at BCCHC and denial of access would have been unethical.  
4.6.2 Limitations 
As with any behavioral intervention, motivations to participate introduce potential biases 
as those who met inclusion criteria but declined to participate represent an unstudied population. 
This limits the generalizability of the intervention [122]. As well, the comparison group received 
health coach support (without mobile monitoring) as opposed to usual care. Not only did this 
enable a more clear understanding of the effect of electronic monitoring of health behavior on 
clinical outcomes, pilot trial findings suggested a usual care control condition (ie, no health 
coaching) would result in an unacceptably high attrition rate in the controls. The lack of 
between-group differences at 6 months may be due to other, more complex factors. For example, 
since health coaches were randomly assigned to participants in both arms, it is possible that more 
effort was expended in coaching the mobile phone-assisted arm. However, since the effect size 
of HbA1c reduction was similar across groups, this was unlikely.  Furthermore, there could have 
been bias in the opposite direction, with health coaches expending more effort in assisting the 
78 
behavior change of control participants since these controls did not have the support of the 
mobile phone interactions. Also, although it would have been ideal to compare multiple glucose 
measures (eg, random blood sugar, fasting blood sugar), it was not possible at the participating 
sites. We were limited to reliable access only to HbA1c blood tests. We recognize, with other 
researchers, that glucose regulation is more complex than what is solely indicated in HbA1c 
assessment. 
4.6.3 Conclusions 
Although this trial did not indicate a significant between-group difference in improved 
glucoregulation, there were overall clinical and statistically significant improvements in HbA1c 
for participants in both health-coached groups. Given the pragmatic trial design, our findings 
suggest health coaching in primary care can improve the glucose management of poorly 
controlled T2DM in lower-SES community residents. It is evident that using mobile phones to 
further connect patients to health coaches and monitor health behaviors can lead to faster 
reductions in HbA1c, which may have specific benefits for cost savings and quality of life.  
Further research comparing health-coaching interventions of different contact intensities, using 
wearable biomonitoring devices, and using a true waitlist/control group will help evaluate health 
coach intervention effectiveness, as well as long-term adherence levels and cost/benefit results. 
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CHAPTER 5: GENERAL DISCUSSION 
5.1 SUMMARY OF FINDINGS 
This dissertation was aimed at determining whether health coaching with (and without) 
the use of smartphone technology could improve glucose management, clinical diabetes 
outcomes and well-being in a lower SES community in Toronto. Lessons learned from the pilot 
trial were instrumental in helping design the RCT protocol. Due to factors that affected our target 
population such as inflexible work schedules and distrust of academic research, we determined a 
usual care control group would have reduced recruitment, resulted in an unacceptable attrition 
rate and contributed to misinterpretations of academic goals and collaboration. This led to the 
decision to provide health coaching to the control group and compare it to health coaching with 
smartphone support. Experience from the pilot also demonstrated needs for adequate control of 
the measurement of our main outcome variable (HbA1c) and, specifically, to overcome 
inconsistent communication and testing from attending physicians, be they primary care 
physicians or endocrinologists. The pilot trial also provided opportunities to increase our 
academic collaboration within the Jane-Finch community of Toronto, which assisted in 
recruitment of the larger trial. It provided time to further develop the health coach curriculum 
and protocol, and recruit undergraduate kinesiology volunteers who were ultimately trained and 
employed as health coaches for the RCT. This pilot period served also to increase collaboration 
with the Black Creek Community Health Centre (BCCHC) and fully integrate the Exercise 
Education Program, a clinically-oriented community exercise program that became usual care at 
BCCHC and a model for other community health and primary care centres (Innovator of the 
Year Award - Association of Ontario Health Centres, 2014). 
The pilot trial, which was executed by a single health coach, resulted in significant 
reductions in HbA1c for participants whose baseline HbA1c values were greater than 7.0% (-
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.43%, p=.04). This finding suggested the RCT eligibility criteria should be set at a sufficiently 
high level that a significant effect-size was achievable and that a transition was theoretically 
reflected from poor glycemic control (≥7.3%) to a level of control where future complications 
would be minimized (7.0 or below). 
The full scale RCT compared health coaching with smartphone support to health 
coaching alone and recruited n=131 participants who were intervened with by 6 health coaches. 
We found no significant differences in HbA1c changes when health coaching was delivered with 
or without smartphone-based connectivity using both per protocol (p=.481) and intention to treat 
(p=.825) principles. However, there were observed strong pre-post within-group effect sizes in 
HbA1c for both experimental and control groups (p=.001). Reductions in HbA1c values have the 
direct benefits of reducing the risks of diabetes-related complications, which are associated with 
significant detriments to quality of life [31], as well as increasing use of health care resources 
[190]. There were also significant reductions in body weight (1.22kg, 95% CI [0.351, 2.08]; 
p=.006) and waist circumference (2.23cm, 95% CI [0.53, 3.93]; p=.011) in the intervention 
group, while the control group had no change. We detected pre-post improvements with the 
Satisfaction with Life Scale for both the intervention (+3.72, 95% CI [1.50, 5.94]; p=.001) and 
control groups (+3.77, 95% CI [1.30, 6.24]; p=.003). Improvements in both groups were 
detected in the HADS-depression subscale (-1.81, 95% CI [-2.81, -.81]; p=.001; -1.70, 95% CI [-
2.73, -.67]; p=.002) and the Physical Composite Score of the SF-12 (+2.69 95% CI [.21, 5.17]; 
p=.034; +2.92 95% CI [.24, 5.60]; p=.033). The control group did demonstrate a significantly 
reduced HADS-anxiety subscale score (-1.50, 95% CI [-2.73, -.27]; p=.017) while the 
intervention group did not (-1.12, 95% CI [-2.29, .05]; p=.060). There were also significant 
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between-group differences detected at 6 months in the Negative Affect subscale of the PANAS 
(5.27, 95% CI [1.51, 9.04]; p=.007) favoring the intervention group. 
5.2 OVERALL LIMITATIONS 
Both studies included in this dissertation contain methodological weaknesses that can be 
addressed in future studies. As with any behaviorally focused intervention, motivation to agree to 
participate introduces potential bias as those who met inclusion criteria but declined participation 
represent an unstudied population with potentially significant implications for intervention 
generalizability.  While the pilot study enrolled only a small convenience sample with no control 
group (limiting generalizability of results), the comparison group in the RCT did receive health 
coach support (without smartphone monitoring) as opposed to usual care. This approach aimed 
to better understand which intervention features are most important in achieving better outcomes. 
But the absence of a third, usual care group (no health coaching), makes it impossible to validate 
the intervention effects.  Despite this limitation, the decision to not include a usual care control in 
this trial was done purposefully to improve retention. Nonetheless, patients with type 2 diabetes 
typically do not improve at the levels observed without significant changes in behaviour [30].  In 
comparison with other HC interventions, our trial had specific differences that merited further 
exploration (especially the positive pre/post differences), in a lower SES population.  It was also 
novel to integrate exercise education as a usual care service in both participating health care 
centre sites. 
The mobile technology also did not always perform as planned. In the pilot trial, some 
participants experienced sporadic software glitches and server downtime that resulted in service 
disruptions. Although participants could directly log healthy behaviour self-observations via 
smartphone, their self-reports (like all self-reports) could have been falsified or exaggerated. 
Future studies could employ Bluetooth connected technology (i.e., glucometers, accelerometers) 
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to omit some self-report biases. While software glitches were minimized in the RCT, Bluetooth 
connected devices were out of the scope of the project and therefore there was still reliance on 
self-reported manual entry.    
In the RCT, health coaches were randomly assigned to provide support to participants in 
both study arms, and it is possible that they purposely invested more effort in coaching the 
smartphone-assisted arm. However, it is likely that this was not the case and based on similar 
results between groups there could have been bias in the opposite direction, with health coaches 
putting more effort into assisting control participants since they did not have the support of the 
smartphone and related interactions. 
Statistical methods employed in both studies separated subsamples from the larger 
sample to conduct the analysis. As we were interested in testing the feasibility of the intervention 
in the pilot trial with all patients, we set no minimum inclusion criteria, which resulted in n=7 
well-managed diabetic patients to be enrolled (HbA1c<7.0%). This subsample had less room for 
improvement in their gluco-regulation, and therefore were more difficult to make any changes in 
HbA1c. To demonstrate an effect with the sample of interest (poorly managed diabetics) we split 
the sample and reanalyzed. This splitting of the sample has implications for validity of results, as 
it was a matter of convenience that the sample be split, and there may be other, underlying 
reasons why participants with <7.0% HbA1c did not change. 
In the full scale RCT, we were most interested in the differences in HbA1c values from 
baseline to 6 months. Nonetheless, the presence of a 3-month time point permitted a trend 
analysis. An independent samples t-test was used as a primary outcome for the baseline to 6 
month difference between groups, and we used a factorial repeated measures ANOVA (group as 
factor) to evaluate trends in the outcomes for both within-group and between-group differences. 
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Unfortunately, due to a small number of participants who did not provide a 3 month measure, the 
ANOVA ignored their measures all together (n=6). Separate analysis on this subsample revealed 
no baseline difference with the rest of participants. Similar literature uses linear mixed effects 
models for analysis of repeated measures, which is able to handle missing data using random 
effects [101,105,106]. In our situation, the decision was made to not use linear mixed effects 
since we had at most only three time points, and were most interested in the difference between 
baseline and 6 months. Using factorial repeated measures ANOVA, there was some data loss, 
but we have a robust outcome illustrating the effects between intervention groups, and within 
intervention groups. 
Finally, both trials relied on HbA1c, although it would have been ideal to compare 
multiple glucose measures (e.g. random blood sugars, fasting blood sugar).  This was simply not 
possible at participating sites. We had reliable access to HbA1c blood tests only. We recognize, 
with other researchers, that glucose regulation is more complex than what is evident in HbA1c 
assessment. 
5.3 FUTURE DIRECTIONS 
Health coaching for the management and prevention of chronic disease is gaining 
momentum in the literature and suggests excellent promise at helping health care systems better 
manage the inflating rates of chronic disease. Ensuring health coaches receive sufficient 
evidence-based training, and maintain an intensity of interaction with participants during the 
intervention period that will elicit the intended behaviour change are important considerations 
when planning health coach interventions. While a mean of 38 minutes (SD 25) per week of 
health coach interaction in our trial produced significant improvements in our sample population 
(in both groups), further research should titrate other intensities of interaction to determine the 
most cost effective intensity levels. While determining optimal levels of health coaching can be 
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difficult due to individual differences in clients and coaches, a range of potential intensities with 
estimated outcome probabilities would help future health coaching interventions anticipate 
personnel costs and anticipate realistic outcomes. 
Although our RCT indicated no significant differences in the primary outcome between the 
mobile vs. health coach only groups, personal testimony regarding the mobile system suggests 
the delivery of health coach interventions will improve when they rely on a combination of 
competent health coaching and the seamless integration of mobile technology in assisting with 
communication with and monitoring of participants [185]. The integration of automatically 
entered behavioural and outcome data into a smartphone monitoring system such as Bluetooth 
enabled accelerometers and glucometers will reduce self-report bias and error, and improve 
health coach/participant interaction efficiency by reducing unnecessary interaction events, and 
increasing timely interactions when a relapse event occurs. As technology improves, patients and 
coaches will have access to better measurement instruments that can monitor in real time, are not 
cumbersome to wear, and indicate deviations from predefined parameters of acceptable 
biomarkers. Examples of upcoming technologies that may be highly beneficial to health coach/ 
patient interaction by providing 24-hour monitoring include heart rate variability [191], ECG 
[192], continuous glucose monitoring [193], and tidal volume variability and respiration rate 
[194]. These technologies will make health coaching patients with other chronic diseases like 
Chronic Obstructed Pulmonary Disorder (COPD), Cardiovascular Diseases, T2DM and Heart 
Failure more precise by integrating disease relevant behaviour change with more sophisticated 
monitoring technologies. 
Health coach interventions will have an even greater impact for Canada’s most vulnerable 
and marginalized populations, who have greater disease prevalence yet use more health care 
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services [176], have more trouble accessing service in Canada’s public health system [165], and 
struggle to manage their conditions [19]. Although more research is needed, as clients change 
their behaviour toward healthier outcomes, they should have fewer complications, less visits to 
the emergency room, and use less health care resources. When titration of health coaching 
intensity is properly balanced, the system should experience a net positive return for health care 
dollars, especially if peer health coaching is utilized [112].  
5.4 CONCLUSION 
 Concerns over the growing prevalence of chronic disease and public healthcare 
sustainability in Canada necessitate creative, evidence-based interventions to reduce systemic 
and personal loss associated with preventable illness. Traditionally, the Canadian Medicare 
system originated as a model that focused on treating acute medical conditions such as trauma 
and infection, where treatments were relatively brief and patients were ‘cured’. Our public health 
system was not intended to manage primarily chronic, lifelong conditions. Tommy Douglas, the 
father of Canada’s medical system stated that, “Only through the practice of preventive medicine 
will we keep the costs from becoming so excessive that the public will decide that Medicaid is 
not in the best interest of the people of the country” – Tommy Douglas [195]. Yet the majority of 
healthcare costs now come from chronic conditions with significant behavioural risk factors 
[196]. Although effort is needed to prevent chronic disease, once a patient develops a condition, 
obtaining optimal control of identifiable disease processes (like blood glucose regulation) is 
pivotal to maintaining quality of life and limiting healthcare expenditures. Health behaviour 
change, with health coach and smartphone support, may prove to be an effective and cost 
effective way to improve the health of patients living with chronic disease.  This set of studies, 
amongst other demonstrations, indicated that individuals with minimal pre-exposures to 
smartphone technology could use the devices effectively, and achieve clinical benefits. 
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Demographics (Appendix A) 
 
• Gender 
o What is your Gender? 
 Male  Female 
 
• Age 
o What is the year of your birth? ____________ 
 
• Ethnicity 
o Which of the following racial or ethno-cultural groups best describe you? 
 Aboriginal (Inuit, Métis, 
North American Indian)  
 West Asian (e.g., 
Armenian, Egyptian, 
Iranian, Iraqi, Lebanese, 
Moroccan) 
 Black - African (e.g., 
African, Somali, etc)  
 Black – Caribbean (e.g. 
Haitian, Jamaican, etc) 
 White (Caucasian – 
European/American) 
 Hispanic 
 Latin American 
 Chinese 
 Filipino 
 Japanese 
 Korean 
 South Asian 
 South East Asian 
 Other (Fill in): 
 ____________________ 
• Language 
o What language(s) do you speak?    
 English   
 French 
 Do you also speak another language (s): 
___________________________ 
 
• Time-in-country 
o How many years have you lived in Canada? 
 # of years or “Since birth”: _____________________ 
 
• Educational Status 
o What is the highest level of education you have completed? 
 Elementary School 
 Middle School 
 High School 
 Some College or University or Trade/Vocational Training 
 Trade, Vocational Training or Certificate 
 College Diploma 
 University Degree 
 Post-Graduate Degree 
• Employment Status 
o What is your employment status? 
 Unemployed 
 Student 
 Part-Time 
108 
 Full-Time 
 Retired 
 Self-Employed 
 Work in the home (take care of children, etc) 
 
• Income Status 
o What is your annual income status? 
 $0 – $9999 
 $10,000 – $25,000 
 $25,000 – $50,000 
 $50,000 – $75,000 
 $75,000 – $100,000 
 $100,000 – Up 
 
• Car ownership 
o Do you own or have access to a car? 
 Own 
 Have access 
 No car access 
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(Appendix B) 
Use of a Blackberry Enabled Health Coach in the 
Self-Management of Type 2 Diabetes 
 
 
 
 
QUESTIONNAIRE PACKAGE 
 
 
 
 
 
 
 
 
 
 
Study ID: _______________ 
 
Date: __________________ 
 
PRE/POST 
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The Satisfaction with Life Scale 
(Appendix B-2) 
 
By Ed Diener, Ph.D. 
 
 
 
 
DIRECTIONS: Below are five statements with which you may agree or disagree. Using 
the 1-7 scale below, indicate your agreement with each item by placing the appropriate 
number in the line preceding that item. Please be open and honest in your responding. 
 
 
 
 
1 = Strongly Disagree 
2 = Disagree 
3 = Slightly Disagree 
4 = Neither Agree or Disagree 
5 = Slightly Agree 
6 = Agree 
7 = Strongly Agree 
 
 
 
 
 
______ 1. In most ways my life is close to my ideal. 
______ 2. The conditions of my life are excellent. 
______ 3. I am satisfied with life. 
______ 4. So far I have gotten the important things I want in life. 
______ 5. If I could live my life over, I would change almost nothing. 
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The Hospital Anxiety and Depression Scale (HADS) 
(Appendix B-3) 
 
Doctors are aware that emotions play an important part in most illnesses.  
If your doctor knows about these feelings s/he will be able to help you 
more. 
This questionnaire is designed to help your doctor to know how you feel.  
Read each item and underline the reply which comes closest to how you 
have been feeling in the past week. 
 
Don’t take too long over your replies: your immediate reaction to each 
item will probably be more accurate than a long, thought-out response. 
 
1. I feel tense or “wound up”:        
3   Most of the time 
2   A lot of the time 
1   From time to time, occasionally 
0   Not at all 
 
2. I still enjoy the things I used to enjoy: 
0   Definitely as much 
1   Not quite so much 
2   Only a little 
3   Hardly at all 
 
3. I get a sort of frightened feeling as if something awful is about to happen: 
3   Very definitely and quite badly 
2   Yes, but not too badly 
1   A little, but it doesn’t worry me 
0   Not at all 
 
4. I can laugh and see the funny side of things: 
0   As much as I always could 
1   Not quite so much now 
2   Definitely not so much now 
3   Not at all 
 
5. Worrying thoughts go through my mind: 
3   A great deal of the time 
2   A lot of the time 
1   From time to time but not too often 
0   Only occasionally 
6. I feel cheerful: 
3   Not at all 
2   Not often 
1   Sometimes 
0   Most of the time 
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7. I can sit at ease and feel relaxed: 
0   Definitely 
1   Usually 
2   Not often 
3   Not at all 
 
8. I feel as if I am slowed down: 
3   Nearly all the time 
2   Very often 
1   Sometimes 
0 Not at all 
 
9. I get a sort of frightened feeling like “butterflies” in the stomach: 
0   Not at all 
1   Occasionally 
2   Quite often 
3 Very often 
 
10. I have lost interest in my appearance: 
3   Definitely 
2   I don’t take so much care as I should 
1   I may not take quite as much care 
0 I take just as much care as ever 
 
11. I feel restless as if I have to be on the move: 
3   Very much indeed 
2   Quite a lot 
1   Not very much 
0 Not at all 
 
12. I look forward with enjoyment to things: 
0   As much as I ever did 
1   Rather less than I used to 
2   Definitely less than I used to 
3   Hardly at all 
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13. I get sudden feelings of panic: 
3   Very often indeed 
2   Quite often 
1   Not very often 
0   Not at all 
 
14. I can enjoy a good book or radio or television programme: 
0   Often 
1   Sometimes 
2   Not often 
3   Very seldom 
 
 
Now check you have answered all questions 
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Positive and Negative Affect Scale (PANAS) 
(Appendix B-4) 
 
 
This scale consists of a number of words that describe different feelings and 
emotions.  Read each item and then mark the appropriate answer in the space 
next to that word.  Indicate to what extent you feel this way right now, that is, at 
the present moment.  Use the following scale to record your answers: 
 
 
1 2 3 4 5 
very slightly 
or not at all 
a little moderately quite a bit extremely 
                           
 
 
 ___ interested    ___ irritable 
 ___ distressed   ___ alert 
 ___ excited    ___ ashamed 
 ___ upset    ___ inspired 
 ___ strong    ___ nervous 
 ___ guilty    ___ determined 
 ___ scared    ___ attentive 
 ___ hostile    ___ jittery 
 ___ enthusiastic   ___ active 
 ___ proud    ___ afraid 
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Your Health and Well-Being (SF-12 v.2) 
 
This survey asks for your views about your health. This information will 
help keep track of how you feel and how well you are able to do your 
usual activities. 
For each of the following questions, please mark an  in the one box that 
best describes your answer. 
 
1. In general, would you say your health is: 
Excellent Very good Good Fair Poor 
     
 1  2   3  4  5 
 
 
2. The following questions are about activities you might do during a typical day.  
Does your health now limit you in these activities?  If so, how much? 
 Yes, 
limited 
a lot 
Yes, 
limited 
a little 
No, not 
limited 
at all 
    
a  Moderate activities, such as moving a table,  
 pushing a vacuum cleaner, bowling, or  
 playing golf ............................................................ 1........... 2 .......... 3      
b  Climbing several flights of stairs ........................... 1........... 2 .......... 3      
 
3. During the past 4 weeks, how much of the time have you had any of the following 
problems with your work or other regular daily activities as a result of your physical 
health? 
 All of 
the time 
Most 
of the 
time 
Some 
of the 
time 
A little 
of the 
time 
None 
of the 
time 
      
a  Accomplished less than you would  
like ............................................................ 1 ...... 2....... 3....... 4 ....... 5    
b  Were limited in the kind of work or  
other activities ......................................... 1 ...... 2....... 3....... 4 ....... 5  
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4. During the past 4 weeks, how much of the time have you had any of the following 
problems with your work or other regular daily activities as a result of any emotional 
problems (such as feeling depressed or anxious)? 
 All of 
the 
time 
Most 
of the 
time 
Some 
of the 
time 
A little 
of the 
time 
None 
of the 
time 
      
a  Accomplished less than you would like... 1 ....... 2 ...... 3 ...... 4 ........ 5    
b  Did work or other activities less  
carefully than usual ................................. 1 ....... 2 ...... 3 ...... 4 ........ 5  
 
5. During the past 4 weeks, how much did pain interfere with your normal work (including 
both work outside the home and housework)? 
Not at all A little bit Moderately Quite a bit Extremely 
     
  1  2  3  4  5 
 
6. These questions are about how you feel and how things have been with you during the 
past 4 weeks.  For each question, please give the one answer that comes closest to the 
way you have been feeling.  How much of the time during the past 4 weeks... 
 All       
of the 
time 
Most    
of the 
time 
Some   
of the 
time 
A little 
of the 
time 
None   
of the 
time 
      
a  Have you felt calm and peaceful? ...... 1 ........ 2 ......... 3 ......... 4 ........ 5    
 Did you have a lot of energy? ............. 1 ........ 2 ......... 3 ......... 4 ........ 5 
c  Have you felt downhearted and  
 depressed? ......................................... 1 ........ 2 ......... 3 ......... 4 ........ 5  
 
7. During the past 4 weeks, how much of the time has your physical health or emotional 
problems interfered with your social activities (like visiting friends, relatives, etc.)? 
All of the 
time 
Most of the 
time 
Some of the  
time 
A little of the 
time 
None of the  
time 
     
 1  2  3  4  5 
 
SF-12v2™ Health Survey  1994, 2002 by QualityMetric Incorporated and Medical 
Outcomes Trust. All Rights Reserved. SF-12® a registered trademark of Medical Outcomes 
Trust. (SF12v2 Standard, US Version 2.0) 
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CONSENT FORM 
(Appendix C) 
TITLE: Investigating Improved Self Management in 
Type II Diabetes  
PRINCIPAL INVESTIGATOR: Dr. Paul Ritvo 
 
You are being asked to take part in a research study. Before agreeing to take part in this 
study, it is important that you read and understand the following explanation of the 
proposed study procedures. 
The following information describes the  
• Purpose  
• Procedures  
• Benefits  
• Discomforts  
• Risks and  
• Precautions associated with this study 
It also describes your right to refuse to participate or to withdraw from the study at any 
time. In order to decide whether you wish to participate in this research study, you 
should understand enough about it to make an informed decision.  
This is known as the informed consent process. Please ask the researcher to explain any 
words you don’t understand before signing this consent form. Make sure all your 
questions have been answered to your satisfaction before signing this document. 
 
PURPOSE: 
You have been asked to participate in a study designed to help you better manage your 
Type II Diabetes through reading especially developed manuals, engaging in face-to-
face meetings and telephone contacts with carefully trained and supervised health 
coaches and using a Blackberry Smartphone that will enable you to record what healthy 
behaviours you do on a day-by-day basis.    
 
PROCEDURES: 
Your participation in this study will entail a time commitment of 6 months.  If you 
agree to participate in this study, you will be asked to complete a set of questionnaires 
that help us understand your experience with diabetes and help us understand you better. 
You will then be randomly assigned to one of two comparison groups 1) the full 
intervention group will receive all the multiple-modalities cited (web-based promotion, 
Blackberry smartphone and HealthCoach software, cell phone text messaging, direct 
exercise promotion and health coaching); 2) the electronic-engagement and usual care 
group who will receive all the multiple modalities (web-based promotion, cell phone 
text messaging, direct exercise promotion) except for use of the Blackberry smartphone, 
HealthCoach software and related health coaching. All participants, regardless of group 
assignment, choose from the set of communication modalities available which they 
want to use at a personally selected intensity level.  
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If you participate in the full intervention, you will also be loaned a Samsung Galaxy 
Ace 2 smart phone that is preloaded with Health Coach Software. This software helps 
you record what you do and can, when agreeable to you, remind you to take 
medications, exercise, eat foods considered healthy, track how you feel. Although the 
Blackberry device will not be able to make or receive phone calls, the data service will 
allow use of the Health Coach software, as well as other data related activities you 
would like to use the device for (ie: email, surfing). You will not be held liable for 
damage or loss of the device. You will have access to a health coach who will further 
assist you in telephone-based and face-to-face discussions. You will, at times, meet with 
your Health Coach at agreed on times for designated time periods. 
To help assess the effectiveness of the program, researchers will ask for you to share 
regularly scheduled blood work results (specifically Hemoglobin A1C) with the 
research team at 3 month intervals. You may also be asked to engage in more than usual 
blood glucose and HbA1c testing. All finger pricking for the purpose of drawing a drop 
of blood to assess blood glucose or HbA1c will be done by you. You will also be asked 
to complete fitness measures including: 
• weight  
• waist circumference 
• body mass index (BMI)  
• Psychological Measures (30-40min to complete):  SF – 12; Profile of Mood 
States – Vigor Scale; Center for Epidemiological Studies Depression Scale; Scale 
of Psychological Well-Being; Positive and Negative Affect Schedule 
RISKS AND BENEFITS 
There are no known personal risks or benefits associated with taking part in this 
research study.  It is our hope that your Diabetes will become more manageable to you 
with the help of this study, and that you will feel more energized and healthier on a 
daily basis. 
CONFIDENTIALITY: 
All information obtained during the study will be held in strict confidence. You will be 
identified by a study number and initials only. Names or identifying information will 
not be used in any publication or presentation.  
Your data will be safely stored in a locked facility and only research staff will have 
access to this information. Data will be retained for five years after publication of the 
study results. Data entered into the Healthcoach program is stored in a secure server and 
not stored on the device. Researchers will be able to monitor any data you store in the 
Healthcoach program.  
This is done to assist you with your health activities (ie: diet and exercise) as well to 
assist researchers in better understanding the best use of the software. Any personal data 
stored in the blackberry (pictures, email) will be cleared upon study completion.  
 
PARTICIPATION: 
Your participation in the study is voluntary. You may withdraw from the study at any 
time, and you can also choose not to answer any questions that you do not feel 
119 
comfortable answering. This will not affect your care. Your refusal to participate or 
your withdrawal from the study will not affect your relationship with the researchers, 
York University or impact the services you receive from Black Creek Community 
Health Centre. If you decide to withdraw from the study and you wish us to destroy the 
information and data you provided, we will do so upon your request.  When you choose 
no longer to be a part of the study, or the study period ends, the blackberry device is to 
be returned to us. 
 
QUESTIONS: 
If you have questions about the research in general or about your role in the study, 
please feel free to contact Dr. Paul Ritvo (York University) by telephone at (xxx) xxx-
xxxx ext. xxxxx or by e-mail or Michelle Westin (Black Creek Community Health 
Centre) by telephone at (xxx) xxx-xxxx ext. xxxx or by email. This research study has 
been reviewed and approved by the Human Participants Review Committee (Certificate 
#: 2012 - 033), York University’s Ethics Review Board and conforms to the standards of 
the Canadian Tri-Council Research Ethics guidelines.  If you -have any questions about 
this process, or about your rights as a participant in the study, please contact Ms. Alison 
Collins-Mrakas, Manager, Research Ethics, Office of Research Ethics, 5th Floor, York 
Research Tower, York University (telephone (xxx) xxx-xxxx or e-mail, or Ms. Cheryl 
Prescod, Executive Director, Black Creek Community Health Centre (telephone (xxx) 
xxx-xxxx ext. xxxxx or email). 
 
Legal Rights and Signatures: 
 
I________________________________, consent to participate in the Investigating 
Improved Self Management in Type II Diabetes research study. I have understood the 
nature of this project and wish to participate.  I am not waiving any of my legal rights by 
signing this form.  My signature below indicates my consent. 
 
               
Name of Participant  Signature of Participant  Date    
 
               
Name of Person   Signature of Person  Date 
Obtaining Consent   Obtaining Consent 
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Data Collection Checklist 
(Appendix D) 
Blackberry Enabled Health Coach in the 
Self-Management of Type 2 Diabetes 
 
Participant: _______________ 
 
□ Consent (Date: ___________) 
 
Baseline Assessment  
□ Demographics (Date: ___________) 
□ Questionnaires (Date: ___________) 
□ PARQ (Date: ___________) 
□ Body Comp (Date: ___________) 
□ A1Cs (Date: ___________) 
□ Randomization (Group: Intervention/Control) 
o Assign Smartphone (#     ) – Give instruction manual 
 
3 Month  
□ Body Comp (Date: ___________) 
□ A1Cs (Date: ___________) 
 
6 Month 
□ Questionnaires (Date: ___________) 
□ Body Comp (Date: ___________) 
□ HbA1Cs (Date: ___________) 
□ Retrieve Smartphone (Date: ___________) 
 
Body Composition Chart 
 Baseline 3 Month 6 Month 
HbA1c    
Weight (kg)    
BMI    
Waist Cir. (cm)    
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(Appendix E) 
Black Creek Community Health Centre 
Investigating Improved Self-Management in Type 2 Diabetes 
1 Yorkgate Blvd, Suite 202, Toronto, ON M3N 3A1 
Phone: (xxx) xxx-xxxx Fax: (xxx) xxx-xxxx 
 
 
 
REQUEST FOR LAB RESULTS AND PERMISSION OF COMMUNICATION 
 
RE: ________________________________ DATE OF BIRTH: ______/______/______ 
             DAY    MONTH    YEAR 
 
_____________________________ (Patient Name) has consented to participate in the research project 
at Black Creek Community Health Centre titled: Investigating Improved Self-Management in Type 2 
Diabetes. 
 
This study is designed to help patients better manage their Type 2 Diabetes through contact with 
specially trained Black Creek CHC health coaches / exercise specialists. Patients will engage in face-
to-face and telephone contact with health coaches who will support them in managing their condition. 
Health coaches are all certified exercise specialists, and will incorporate safe and effective exercise 
modalities into patients’ care routines, as well as support other health related behaviours as indicated 
by their care team (diet, medication, etc.).  
 
Please fax the most recent results of any pertinent lab results including: HbA1C, fasting glucose, 
cholesterol profile, liver function test, albumin/creatinine ratio, creatinine, eGFR, and Microalbumin to 
416-650-0971. 
 
Declaration 
I, ________________________, give permission for my health care team (which may include my 
physician, nurse practitioner, dietitian and diabetes nurse educator) to share information with my 
health coach on any matters that may help me better manage my diabetes, and health coach to share 
information with my health care team. This may include discussing my participation in this study, the 
sharing of blood test results, dietary practices, exercise routines and other information that is directly 
associated with my diabetes management, until such time as I rescind this permission or my 
participation in the study ends. 
 
Signatures 
Client Name: _________________________  Signature: ________________________ 
Date: ______________________ 
 
Witness Name: _______________________   Signature: ________________________ 
Date: ______________________ 
 
Please contact us if you require any other information 
 
Health Coach: ______________________   Signature: ________________________ 
Phone Number: (xxx) xxx-xxxx   Date: ____________________________ 
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Appendix F – Recruitment Poster 
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Appendix G – Recruitment Tri-Fold 
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Appendix H – Information Sheet (Participant) 
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Appendix I – Information Sheet (Provider) 
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Appendix J – Study Summary Sheet (Provider) 
Public Health Agency of Canada 
Investigating Improved Self Management in Type II Diabetes 
 
 
Summary of the Project: 
This study is designed to help patients better manage their Type II Diabetes through contact with 
specially trained Black Creek CHC health coaches / exercise specialists. Patients will engage in 
face to face and telephone contact with health coaches who will support them as they manage their 
condition. Using a Blackberry Smartphone, patients will be able to record what healthy behaviours 
they do on a day-by-day basis. Health coaches are all certified exercise specialists, and will also 
incorporate safe and effective exercise modality into patients care routine. 
 
Recruitment 
The target sample size for the program is 120 participants, evenly randomized into an intervention 
(smartphone) group and augmented control (everything but smartphone) group. The control group 
will still receive exercise and health coaching support. 
 
Inclusion Criteria 
The program is available to patients of Black Creek CHC with Type 2 Diabetes who are younger 
than 70 years old and have a baseline HbA1c => 7.3%. 
 
Timeline 
The study intervention length is six months long and it is scheduled to complete March 2014. 
Recruitment will continue until September 2013, at which point active recruitment will end. 
 
Recruitment Process 
Recruitment Method #1 – Black Creek staff are calling a list of patients with type 2 diabetes and 
inviting them to participate. 
Recruitment Method #2 – Through promotion at diabetes classes, participants are invited to 
participate. 
Recruitment Method #3 – Referrals directly from health care providers 
 
Ethical and Study Staff 
Once patients agree to participate, they read, understand and sign an informed consent document 
which outlines the details of the project.  
 
Health coaches are employees (and one placement student) who have been hired by the Black 
Creek CHC Diabetes Education Program to carry out this study. 
 
Communication: Once a client is recruited into the study, Health Coaches contact the BCCHC 
providers. Providers and Health Coaches have consent from clients to share information that is 
deemed relevant to the study, and the client’s self-management of diabetes. 
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Appendix K – Study Referral Form 
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Appendix L – Physical Activity Readiness Questionnaire + (PARQ+) 
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Appendix M – Research Ethics Approval – Pilot Study 
 
 
 
 
 
Memo 
 
To: Professor Paul Ritvo, Faculty of Health, pritvo@yorku.ca 
 
From:  Alison M. Collins-Mrakas, Sr. Manager and Policy Advisor, Research Ethics 
  (on behalf of Daphne Winland, Chair, Human Participants Review Committee) 
 
Date: Friday 5th February, 2010 
 
Re: Ethics Approval 
 
Diabetes Self Management in Individuals from Modest Socieconomic Status (SES) 
Backgrounds 
 
I am writing to inform you that the Human Participants Review Sub-Committee has 
reviewed and approved the above project. 
 
Should you have any questions, please feel free to contact me at:  (xxx) xxx-xxxx 
or via email. 
 
   Yours sincerely, 
 
    Alison M. Collins-Mrakas M.Sc., LLM 
    Sr. Manager and Policy Advisor,  
Office of Research Ethics 
  
Office of 
Research Ethics 
(ORE) 
 
5th Floor, 
York Research Tower, 
4700 Keele St. 
Toronto ON 
Canada  M3J 1P3 
Tel  416  736 5914  
Fax 416 650 8197 
www.research.yorku.ca 
Certificate #: 2010 - 037 
 
Approval Period:  02/05/10-02/05/11 
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Appendix N – Research Ethics Approval – RCT Study 
 
 
 
 
 
 
Memo 
 
 
  
To: Professor Paul Ritvo, Faculty of Health, pritvo@yorku.ca, noway@yorku.ca 
 
From: Alison M. Collins-Mrakas, Sr. Manager and Policy Advisor, Research 
Ethics 
(on behalf of Wade Cook, Chair, Human Participants Review Committee) 
 
Date: Tuesday 14th February, 2012 
Re: Ethics Approval 
Investigating Improved Self Management in Type II Diabetes 
 
I am writing to inform you that the Human Participants Review Sub-Committee has 
reviewed and approved the above project. 
 
Should you have any questions, please feel free to contact me at:  (xxx) xxx-xxxx 
or via email. 
 
   Yours sincerely, 
 
    Alison M. Collins-Mrakas M.Sc., LLM 
    Sr. Manager and Policy Advisor,  
Office of Research Ethics 
 
Office of 
Research 
Ethics (ORE) 
 
5th Floor, 
York Research Tower, 
4700 Keele St. 
Toronto ON 
Canada  M3J 1P3 
Tel  416  736 5914  
Fax 416 650 8197 
www.research.yorku.ca 
 
Certificate #: 2012 - 033 
 
Approval Period: 02/14/12-02/14/13 
